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I. INTRODUCTION 
OBESITY AND MORBID OBESITY 

1 
A. DEFINITION AND COMPLICATIONS 
For a condition that is of concern to so many people, from weight¬ 
conscious teenagers and their parents losing the battle of the bulge, 
to nutritionists and physicians analyzing trends and risks, obesity has 
proved to be remarkably difficult to define. Most of us use a loose 
inspection test, somewhat akin to the classic definition of an alcoholic 
as someone who drinks more than his physician does. Mayer states that 
"...the only possible logical definition of 
obestity rests on defining at what point 
the proportion of body weight represented 
by fat becomes abnormally high. Exact defi¬ 
nition of this limiting value is arbitrary." (118) 
He suggests that when fat makes up 30% of body weight, a person is obese. 
Others have accepted this figure for women, but would allow a man's body 
19 
weight to be only 25% fat. 
The difficulty that arises is how to measure body fat. Direct meas¬ 
ures of body fat in cadavers are accurate but have limited applications 
to clinical research for obvious reasons. Indirect measures break down 
into three general categories. First, isotopes can be used to estimate 
body water or lean body mass, from which figure an approximation of body 
fat can be derived. Second, body density studies, involving weights both 
in and out of water, give fairly accurate estimates of body fat because 
of the different densities of fat and lean body mass. Finally, various 
anthropometric means are used: namely skinfold thickness, height, and 
weight. Because of inherent difficulties in technique, isotope studies 
and densitometry are not feasible for routine use. For practical purposes, 
antropometric means are almost universally employed. Triceps skinfold 
thickness is held to be a more direct measure of body fat than the ratio 
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of body weight to a somewhat arbitrary "ideal" weight. However, repro¬ 
ducibility is a problem: there may be large variations in measurement 
depending upon the calipers used and pressure applied. Many investigators 
have fallen back on tables of "ideal body weight" prepared by insurance 
companies. The "ideal weight" is an arithmetic mean of weights of insured 
persons of a given height and sex. One can easily fault these tables: 
the insured population is skewed toward the wealthier members of society 
and occupational differences are ignored. Weights are taken with the 
individual "ordinarily dressed," and heights are often recorded with the 
shoes on. Since all these tables originate in the United States, appli- 
97 118 
cability in other countries is questionable. * With all their weak¬ 
nesses, however, the insurance company tables are convenient to work with 
and are used widely. Accepting the limitations of the "ideal weight," 
obesity has been defined as a weight greater than 20% over ideal body 
weight for height."^ The term morbid obesity has been used for those 
obese subjects whose weight is twice ideal or greater than 100 pounds 
.. , 146,172 
over ideal. 
The incidence of the somewhat arbitrarily defined condition of obesity 
is quite surprising. The U.S. Public Health Service estimates that any¬ 
where from 25 to 45% of Americans over age 30 are more than 20% overweight. 
Similarly 2 to 15% of children are obese, as defined by a weight 40% 
205 208 
over the median for height. * In both children and adults, obesity 
is more common in the lower socioeconomic classes: for women, "extreme 
overweight" is seven times as frequent in the lower socioeconomic classes 
90 
as in the upper classes. Age is also an important factor. In all 
studied species of mammals, as the mature animal ages proportionately 
more of the body weight goes to fat, even without an increase in body 
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118 
Forbes and Reina have shown that lean body mass, as measured 
98 
weight. 
40 by K, declines with age in adults, and the rate of this decline increases 
with advancing years.~^ Not only does the proportion of fat increase 
with age, but in the U.S. and many other developed countries body weight 
also increases after age 25. This has important implications in evalu¬ 
ating the risks associated with obesity — obese people will tend to be 
older and thus at increased risk, for example, for cardiovascular disease. 
What exactly are the risks associated with obesity? Insurance 
companies have long been charging an extra premium for obesity because of 
excess mortality. According to insurance statistics, overweight men 
have a mortality rate 1.5 times that of standard insured risks. Those 
who are moderately overweight (30-35% over ideal weight) have a mortality 
rate 1.4 times normal; men who are 40-55% over ideal weight have a mor¬ 
tality rate 1.8 times normal.’*’’^ Mortality rates for obese women are 
similar but less dramatically increased. When the diseases contributing 
to this excess mortality are examined specifically, the main offenders 
12 
are found to be cardiovascular disease, diabetes, and gallstones. 
Obese men with a moderate elevation in blood pressure demonstrate a 60% 
increase in mortality rate when compared to their normal counterparts. 
Men with severe hypertension who are markedly obese have a mortality 
143 
rate 3-4 times standard. Mortality from cardiovascular disease is 
1.5 times normal in obese men and 1.75 times normal in obese women. 
Death rate from diabetes is almost 4 times standard in both obese men 
and women. Mortality rate from cirrhosis, gallstones, and appendicitis 
111 is approximately twice normal prevalence rates. With weight reduction, 
insurance statistics indicate that mortality rates decrease. In moderately 
obese men and women who were re-rated for insurance after weight loss, 
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mortality rate fell from 1.4 times standard to 1.1 and 0.9 respectively 
Some caution must be used in interpreting insurance statistics. 
The 1959 Build and Blood Pressure Study concluded that any degree of ex¬ 
cess weight was a risk to health, but re-evaluation in 1966 demonstrated 
that the increased mortality was seen mainly at levels of extreme obe- 
90 
sity. It is of interest, then, to review current medical thinking re¬ 
garding the complications of obesity. 
Hypertension. A number of studies have found hypertension to be 
^ i , 20,67,98,109,141,217 
more common among the obese, particularly the morbidly obese. 
The Framingham Study revealed that both blood pressure and weight increase 
with advancing age in women. Using age-adjusted groups, it was found 
that average BP increased with relative weight (patient's weight/standard 
weight) in both men and women, but the correlation of systolic BP and 
relative weight was only a modest one (r = 0.3, p < 0.05). However, the 
relative weight correlated more closely with systolic BP than did either 
the triceps skinfold measurement or the upper arm girth. Another impor¬ 
tant observation was an increased prevalence of obesity (relative weight 
> 120) among those subjects who were hypertensive (systolic blood pres¬ 
sure > 160 and/or diastolic blood pressure > 95). 
TABLE 1 
91, (modified from Kannel et al. ) 
PER CENT OBESE 
ENTRY BLOOD 
PRESSURE 30-39 
AGE (Years) 
40-49 50-59 
Normal 2.1 4.1 2.9 
Borderline 12.9 7.5 6.5 
Hypertensive 18.8 16.0 13.1 
Trends for each age group significant (p < 0.05) 

Initially normotensive obese subjects were more prone to develop 
hypertension than their counterparts with normal weight. Eight years 
after entry into the study the incidence of hypertension in originally 
5 
normotensive obese subjects was 3.2 times expected (p < 0.05). In fact, 
"subsequent development of 'hypertension* was shown to be related not 
only to gross 'obesity' but to relative weight, per se, as determined on 
91 
the initial examination." 
Weight loss in both the obese and nonobese over the 12 year follow-up 
period was associated with a fall in blood pressure in both men and 
91 
women, and weight gain with a rise in blood pressure. Fletcher studied 
a group of obese hypertensive women (systolic BP >150 or diastolic > 90) 
who lost weight. Those with systolic hyper tension who lost more than 14 
pounds (average 33 pounds) had a mean fall in systolic BP of 33 mm Hg.; 
those with diastolic hypertension had a mean decrease in diastolic BP 
of 16 mm. These changes were statistically significant when compared to 
53 
the hypertensive women who lost less than 14 pounds. 
There is evidence, then, that the obese are prone to hypertension 
67 (essential hypertension, not renovascular or secondary hypertension ). 
With weight loss blood pressure tends to fall. Kannel also reports that 
lean hypertensive subjects are more likely to become obese than lean 
normotensives, leading him to conclude that the relationship between 
91 
adipose tissue and hypertension is "neither simple nor direct." 
One specter that has been raised with regard to all studies of 
obesity and hypertension is the possibility of an artifactual elevation 
in blood pressure due to cuffs too small for obese arms. That such cuff 
artifact is possible even in nonobese patients is clear from a report 
by Orma et al., in which all patients had elevated blood pressures the 
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first day that a new cuff was in use. The difficulty was related to a 
142 
short bladder size in the new cuffs. Numerous studies have examined 
the relationship between direct and indirect measurement of blood pressure. 
Alexander compared cuff pressure and intra-arterial pressure in a group 
of obese patients and found identical values 50% of the time; the other 
50% split equally between cuff pressures higher and those lower than 
direct.^" Berliner also recorded simultaneous direct and indirect blood 
pressures. He found minor discrepancies in both directions in the lean 
and moderately obese, and a considerable error of the indirect measurement 
in the extremely obese, in whom both systolic and diastolic pressures 
tended to be overestimated.^^ However it should be noted that his cuff 
length was 20 cm. — 3 cm. shorter than the cuffs which created the arti¬ 
fact in normals noted by Orma. 
The Framingham Study addresses this issue by utilizing forearm blood 
pressure and by reanalyzing the data with obesity defined in terms of 
arm girth. Blood pressure readings of hypertensive patients (standard 
cuff) were repeated using the cuff around the forearm and auscultating 
at the radial artery. The loss of hypertensive readings using this 
technique was minimal: basically the equivalent of a repeat blood pressure 
reading on the upper arm. Kannel points out that normotensive obese 
subjects, who presumably had fat arms, had a definite tendency to develop 
hypertension on follow-up. When patients were reclassified by arm girth, 
the frequency of hypertension in obese patients was similar with or without 
large arm girth; conversely, the groups with big arm girths had a variable 
frequency of hypertension depending upon relative weight. Kannel concludes 
that "arm girth produces no independent effect on blood pressure."^ 
Thus while a cuff artifact may exist (particularly in the morbidly obese), 
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the evidence is equivocal as to its significance. The use of a thigh 
cuff in the obese does not seem to be necessary when forearm blood pres¬ 
sures are so much more convenient. 
Cholesterol and triglycerides. The correlation between obesity and 
139 
elevated cholesterol tends to be weak. Montoye et al were able to 
demonstrate a small correlation between serum cholesterol and skinfold 
125 
thickness in men under 50 years of age. Mann's data reveals a slight 
109 
correlation of obesity with cholesterolemia. Despite the poor corre¬ 
lation, induction of obesity by overeating results in elevated lipid 
109 
levels. Twenty-five to forty percent of morbidly obese patients have 
9 20 
elevated cholesterol levels. * Cholesterol levels decline with weight 
loss, sometimes drastically^,109,139 
Plasma triglyceride levels in man are intimately related to carbohy¬ 
drate intake. High carbohydrate diets increase and carbohydrate restric¬ 
tion decreases circulating triglycerides ^^0,56 qq^g effect of carbohy¬ 
drate intake on triglycerides may be mediated by changes in plasma 
48 
insulin. There is a significant correlation between fasting insulin 
139 
and fasting triglyceride (r = 0.43, p < 0.01). Olefsky postulates 
that, elevated insulin levels in obesity augment hepatic triglyceride 
synthesis, thereby leading to hypertriglyceridemia. After weight loss 
averaging 10.9 kg. in moderately obese subjects (mean relative weight 121) 
plasma triglyceride decreased markedly (319 -> 180 mg/100 ml, p < 0.0001) 
139 
in conjunction with a similar decline in plasma insulin. It has not 
been established whether alterations in triglyceride homeostasis in 
obesity are related directly to carbohydrate intake or to hyperinsulinemia 
Coronary heart disease. Insurance statistics show that a large 
proportion of the increased mortality in obese subjects is due to 
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cardiovascular disease.^ Master et al demonstrated that almost 
twice as many men with angina, acute coronary insufficiency, and acute 
coronary occlusion were overweight or obese.The Framingham Study 
shows an increased incidence of angina and sudden death in obese men but 
not obese women. Excluding men with systolic hypertension or hyper¬ 
cholesterolemia, the risk of developing angina or sudden death was twice 
normal in those who were obese (relative weight > 120) . The risk of 
myocardial infarction, on the other hand, was found to be related primarily 
92 
to hypertension and hypercholesterolemia, and not to excessive weight. 
The relationship between obesity and coronary heart disease has come 
under close scrutiny in recent years. Keys criticized the Framingham 
report for lumping all ages together. Applying multivariate analysis to 
the original data, he come to the conclusion that relative weight is a 
risk factor for coronary heart disease in men of 40-49 years, but not 
for ages 30-39 or 50-59. He also pointed out that the increased risk is 
98 
for heart disease diagnosed by soft criteria (i.e., angina). The 
implication is that clinicians are overdiagnosing nonspecific symptoms 
in the obese patient as coronary heart disease. A longitudinal study 
in Evans County, Georgia was unable to demonstrate a relationship between 
overweight and sudden death.^ Chapman et al could not find a consis¬ 
tent association between angina and myocardial infarction and the weight 
index (height in inches/cube root of weight in pounds). Mann concludes 
that coronary heart disease is related to hypertension, not obesity 
109 
per se. 
Cerebrovascular accidents. Both obesity and weight gain after age 
20 are associated with an increased incidence of cerebrovascular disease. 
According to the Evans County, Georgia Study the lowest incidence of 
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strokes occurred in subjects who weighed under 150 pounds at age 20 and 
gained less than 30 pounds thereafter. Similarly the highest incidence 
was seen in the group weighing over 150 pounds at age 20 who gained more 
than 30 pounds since. Weight at age 20 and weight gain after 20 exerted 
independent effects on cerebrovascular disease. Heyden postulates that 
the effect of weight gain on subsequent stroke is mediated through the 
accompanying elevation of blood pressure. Weight in young adulthood 
acts through another, as yet unidentified mechanism.^ 
Glucose intolerance. The association between obesity and glucose 
intolerance has been recognized for many years. Fifty to sixty percent 
93 
of obese subjects have an abnormal glucose tolerance test. More im¬ 
portantly, 75-85% of adult-onset diabetics are obese. The likelihood 
of developing diabetes is 3 times normal in anyone 15% or more over ideal 
140 
weight, and 8 times normal in those who are 25% or more over ideal. 
In 1963 Karam et al observed that obese subjects with normal glucose 
tolerance tests had elevated basal serum insulin levels compared with 
nondiabetic normals. Nine of the 10 obese subjects had prolonged ele- 
93 
vated insulin levels in response to a glucose load. Bagdade et al 
demonstrated a correlation between the fasting level of insulin and per 
cent ideal body weight, but not between fasting insulin and glucose 
intolerance. The insulin response to a glucose load was proportional 
to fasting insulin levels. Both obese and nonobese diabetics had a lesser 
increment in insulin after glucose than did obese and nonobese nondia- 
4 
betics. Perley and Kipnis showed that serum insulin at comparable glucose 
levels was lower in obese diabetics than in obese nondiabetics. 
Genuth measured insulin production and estimated a normal value at 
31 units/24 hrs. Obese diabetics produced about 46 units/24 hrs. and 

10 
61 
obese nondiabetics 114 units/24 hrs. 
Most obese patients are resistant to insulin, as a consequence of 
tissue insensitivity rather than faulty synthesis of a circulating antago¬ 
nist. The response of obese subjects to exogenous insulin is invariably 
reduced. Recent studies suggest that this effect may be mediated by 
changes in insulin receptors. Studies in obese animals have shown a 
decreased number of insulin receptors per adipocyte, and evidence is 
mounting that obese humans have fewer insulin receptors both in circulating 
5 135 
monocytes and adipose tissue. ’ Whether such important insulin target 
tissues as the liver and muscle are similarly affected has yet to be 
138 determined. Although a decreased number of receptors might be expected 
to produce the hyperinsulinemia observed in obesity, some observers have 
suggested that insulin may control the number of its own membrane recep- 
135 43 
tors. * According to this theory, increased carbohydrate intake 
is followed by increased insulin output, which decreases the number of 
receptors on target cells. Thus hyperinsulinemia may actually be the 
primary event inducing insulin resistance. 
A decrease in the number of insulin receptors on a cell does not 
necessarily produce a decreased response to insulin. Maximal stimulation 
of glucose uptake occurs when only a small proportion (about 10%) of insulin 
137 
receptor sites are occupied. A defect distal to the membrane binding 
of insulin has been postulated to explain insulin resistance in some 
cells. Olefsky has found an abnormally low rate of glucose oxidation in 
adipocytes from obese rats. The defect has been localized to the 
1 38 hexose monophosphate shunt. 
Thus obesity seems to lead in some way to insulin resistance, either 
via decreased number of insulin receptors or through a more distal mechanism. 
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Some obese patients with hyperinsulinemia have normal glucose tolerance. 
The obese diabetic, although hyperinsulinemic compared to normals, pro¬ 
duces less insulin than the obese nondiabetic. With weight loss insulin 
resistance improves^, and the available insulin of the obese diabetic 
may be adequate for his needs. With continued obesity and diabetes, one 
can anticipate all the cardiovascular, renal, and ocular complications 
seen in nonobese diabetics. Certainly diabetes is a significant, life¬ 
shortening complication of obesity. 
Pickwickian Syndrome. Burwell originally labeled the syndrome of 
extreme obesity, hypoventilation, somnolence, polycythemia, and right 
ventricular failure a "Pickwickian Syndrome", after the fat boy in 
, 30 
Dickens Pickwick Papers. Hypercapnia is responsible for the somnolence 
and occasional twitching; hypoxia leads to secondary polycythemia, pul¬ 
monary hypertension, right ventricular hypertrophy, and eventually right 
heart failure. There is controversy over the underlying cause of the 
hypercapnia and hypoxia. An increased work of breathing has been postulated 
to lead to hypoventilation. Pickwickian patients tend to have a low 
expiratory residual volume, vital capacity, and total lung capacity. >70 
(These abnormal lung volumes may be related to increased intraabdominal 
pressure.) Compliance is reduced as the lung approaches expiratory 
volume , and the work of breathing is greater. It has been suggested 
that altered mechanics of breathing alone should not lead to hypoventi¬ 
lation. Of interest in this regard is that the ventilatory response to 
both hypoxia and hypercapnia has been shown to be markedly reduced in 
229 
obese hypoventilators. With weight loss the sensitivity of the 
respiratory center to CO^ returns to normal. Weight loss does not, however, 
correct the depressed ventilatory response to hypoxia. ^>229 Fried et al 
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have suggested that ketosis, rather than weight loss per se is responsible 
for the improvement in CO^ sensitivity, but their patients were not overly 
,58 
Pickwickian, nor did patients serve as their own controls. 
It is likely that both extreme obesity and an abnormal ventilator” 
229 
drive are necessary to produce hypoventilation. Weight loss has a 
dramatic effect. When a certain weight is reached symptoms disappear, 
only to return when weight creeps above this threshold level. If weight 
loss can be maintained patients are apparently cured. 
Fatty liver. Abnormal LFT’s are common in the obese, particularly 
sensitive, nonspecific indices. BSP retention is abnormal in 76-100% of 
cases, according to reported series; thymol turbidity and cephalin floe- 
9 218 228 
culation are also frequently abnormal. * * Some degree of fatty 
infiltration can be demonstrated on liver biopsy in 60-100% of obese 
9 102 
subjects. * 7. el man described moderate to marked fatty changes in 10 
of 19 obese noncirrhotic subjects. Those with longstanding obesity were 
22 8 
more likely to have degenerative parenchymal changes as well. “ Kern 
examined 151 liver biopsies of morbidly obese patients undergoing intes¬ 
tinal bypass surgery and found fatty metamorphosis in 94%. Changes of 
periportal fibrosis were present in 42 of the 151 cases, with moderate or 
marked fibrosis in an additional 8. Three cases were suggestive of 
early portal cirrhosis, and 3 showed changes characteristic of Laennec's 
cirrhosis. Kern suggested that this spectrum of fibrotic changes might 
represent progression from the original "benign" lesion of fatty infil¬ 
tration.^ 
Although insurance statistics show that more obese individuals die 
. . . . Ill , 
ot cirrhosis , there is no proof of a causal relationship. Fatty 
infiltration secondary to obesity can be mobilized over 4 to 6 weeks with 
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weight loss. 
102 Westwater and Fainer have noted improvement in abnormal 
liver function tests in several obese patients after weight loss to within 
218 
15% of ideal weight. Thus both the pathological changes of fatty 
liver and the mild abnormalities of liver function appear to be reversible. 
It is possible that obese nonalcoholics develop cirrhosis after long¬ 
standing fatty infiltration of the liver, but it is doubtful that this 
occurs with any great frequency. 
Other medical complications. Obesity is a major risk factor in 
pregnancy for both mother and child.xn one series, 12% of maternal 
deaths occurred in women who weighed over 200 pounds.The incidence 
20 
of gallbladder disease is 2 to 3 times normal in the obese. Obesity 
176 
is associated with carcinoma of the endometrium. The risks of anes¬ 
thesia and surgery are greater for those who are overweight. Osteoarthri¬ 
tis, affecting mainly the back, hips, knees, and ankles, causes a great 
deal of morbidity, and the extremely obese are more likely to develop 
95 
these degenerative changes. Lymphedema, venous stasis, and intertrigi- 
28 217 
nous dermatitis are frequent problems. * Finally obese individuals 
are involved in more accidents. 
Psychosocial complications. Psychiatrists have had much to say 
about the obese personality, concentrating on neurotic characteristics. 
Rubin’s obesity profile includes an obsessive preoccupation with food; 
an excess of all oral activities (not only eating and smoking, but talking, 
smiling, and laughing); eating binges followed by rationalization and 
2 A 
then guilt; and finally a distorted body image. Others have found 
that the obese are more prone to depression, which they tend to accept 
36 
in a passive way rather than struggling against it. Stunkard’s careful 
studies have demonstrated only two behavioral disturbances clearly related 
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to weight: overeating and a body image distortion. He found that many 
of his patients were preoccupied with weight. They felt that their bodies 
were grotesque and disgusting, and were convinced that others felt the 
same contempt. Emotionally healthy adults did not have a body image dis¬ 
turbance, but emotionally unstable adults whose obesity had begun in 
childhood or adolescence commonly did. Weight loss did not have any ef¬ 
fect on the distorted body image, but psychotherapy was thought to be 
, . , n 199,201 
helpful. 
It is not surprising to find that many obese people believe that 
their bodies are disgusting to others. Certainly in our society there is 
a stigma attached to being obese. Women in particular are supposed to be 
thin to conform to our cultural values of youth and sexuality. In cultures 
which define femininity in terms of mothering and childbearing, what we 
call obesity is considered perfectly normal. Obesity carries less of a 
social disadvantage for men in Western society. As Kalisch states, 
"The appearance of men is important, but 
financial status, educational achievement, 
and occupation affect his value more." (90) 
It is important not to discount the significant emotional complica¬ 
tions of obesity. Call this what you will — a body image distortion or 
a neurotic personality — it simply reflects societal discrimination 
against those who are overweight. Even the most stable individual cannot 
help but be affected in both work and social situations. The "happy-go- 
lucky" outlook worn by many overweight people covers the scars, from years 
of emotional trauma. Weight loss means more than a number of pounds or 
fewer medical risks: it means normality, acceptance, a chance to start all 
over. At the same time it represents an unknown to be feared. To suc¬ 
cessfully serve the patient, the physician must deal with all aspects of 
the problem of obesity. 
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B. ETIOLOGY 
Despite the common lay belief that most fat people have an endocrine 
problem, very few of them actually do. In a small proportion of cases, 
obesity may be attributed to genetic, central nervous system, or endocrine 
disease. Clearly genetic types of obesity exist: the Laurence-Moon-Biedl 
syndrome, hyperostosis frontalis interna, the Prader-Willi syndrome, are 
all typified by marked overweight. CNS pathology (hypothalamic tumors, 
Frohlich's syndrome, and trauma) can lead to obesity. The endocrinopathies 
that are blamed so frequently include islet cell dysfunction (varying from 
hyperplasia to insulinoma), chromophobe adenomas of the pituitary, Cushing’s 
syndrome (primary and iatrogenic), hypothyroidism, and pseudohypopara- 
19 119 
thyroidism. ’ (It is interesting to note that in hypothyroidism and 
pituitary disorders, weight loss from dieting has at times been found to 
improve and even reverse the signs of glandular insufficiency, suggesting 
that low levels of hormone were present but inadequate for large body 
N 227 
size.) 
Genetic abnormalities, aside from those syndromes mentioned, seem to 
have a more general role to play. In rats there is clear mendelian trans¬ 
mission of obesity, and the obesity of yellow-coated mice can be assigned 
to a dominant gene. The obese hyperglycemic syndrome in mice is attribu- 
118 
table to a single recessive gene. In humans obesity in childhood has 
3 A 
been found to be associated with an increased incidence of adult obesity. 
Identical twins have closely correlated body weights.Sixty-nine to 
7 2 118 
eighty-two per cent of obese subjects have an obese parent. ’ However 
environmental factors have not been controlled in any of these studies 
and the role of genetics is still not clear. 
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At the most basic level, obesity is always the result of a positive 
23 
energy balance. Either decreased energy expenditure or increased 
caloric intake can lead to such a positive energy balance. Several groups 
have concentrated on decreased physical activity in the obese, suggesting 
that the body’s regulation of input to output does not function normally 
at very low levels of activity. Mayer et al demonstrated that, in general 
food intake decreases with decreasing activity; however, at low levels 
120 
of activity, diet may not be curtailed proportionately. There are a 
number of difficulties with this ambitious study, including the fact that 
diet was determined by history only. Although studies have shown that 
the obese are less active than normals (particularly obese women), it is 
impossible to conclude that the decreased activity is primary, and not a 
secondary effect of obesity. ^ 
An increased efficiency of metabolism has been postulated as a mech¬ 
anism for decreased energy expenditure. It has been assumed that basal 
caloric expenditure is constant over the entire range of caloric intake. 
However, when Bray measured resting energy expenditure after a semi¬ 
starvation diet in 6 obese women, he found a decrease of 15% from baseline 
He postulated a shift in intracellular glucose metabolism away from the 
energy-wasting glycerophosphate cycle (in which reducing equivalents are 
shunted into mitochondrial oxidative phosphorylation at the flavoprotein 
level, yielding only 2 ATP instead of a potential 3 ATP). He was able to 
demonstrate a decreased amount of both soluble and mitochondrial glycero¬ 
phosphate dehydrogenase (the key enzyme) in subcutaneous fat biopsies 
from patients under caloric restriction.^ Assays of the enzyme in a 
second study showed reduced levels in obese patients compared to normal 
controls, with a further drop on dieting. Animal studies suggested 

17 
that the enzymes of the glycerophosphate cycle were partly controlled 
by thyroid hormone, which led Bray to treat his obese patients with 
18 
tri-iodothyronine. Large doses were required, however, and it is 
difficult to attribute the entire weight loss to an increased activity 
of glycerophosphate dehydrogenase. The finding of a decreased basal 
caloric expenditure when intake is reduced certainly has implications 
for dieters — namely, weight loss will not necessarily occur as quickly 
as predicted. 
The thermal dissipation, or "Luxuskonsumption," theory has also been 
resurrected to explain a decreased energy output. Several amazing studies 
of obesity induced in normals by massive overeating have revealed an in¬ 
creased heat production that dissipates much of the excess caloric intake 
and results in a weight gain remarkably less than predicted.109,123,124 
Basal metabolic rate remains unchanged, and 24 hour oxygen consumption 
must be measured to appreciate the increased heat production, which 
occurs primarily after meals. The thermic response is shown to be pro¬ 
portional in both size and duration to the caloric content of the meal 
and is more marked if the subject exercises after eating (even excluding 
124 
the heat loss from exercise). Proponents of this theory hypothesize 
that the obese have a less than normal thermal dissipation in response 
to increased caloric intake, leaving them with a positive energy balance. 
Caloric intake is controlled by a number of factors: the hypo thalamus, 
behavioral patterns, psychological conflicts, and social customs. The 
ventromedial nucleus of the hypothalamus has been found to be the satiety 
center in humans, with a hunger or food-seeking area located laterally. 
There are a number of theories as to how the "appestat" works, including 
(1) the detection of small increments in heat produced by metabolism of 

food; (2) sensitivity to changes in glucose concentration (glucostatic 
theory); or (3) nervous stimuli.15,109,118 Although gross lesions in 
the ventromedial hypothalamus in animals, produced by gold thioglucose 
or a stereotaxic lesion, have induced massive obesity with a complete 
109 
absence of satiety , it is difficult to apply these studies to humans. 
One study that relates adult obesity and lean-ness to periods of plenty 
or famine in early life postulates that the hypothalamus is "set" early 
15 8 
in life depending on the available food supply. Such subtle defects 
in the "appestat" are beyond our present capabilities of detection and 
remain theoretical. 
There is evidence that eating patterns in the obese differ from the 
norm. Schachter found that the obese were less responsive to internal 
cues regarding satiety and tended to make decisions on food intake de¬ 
pending on external cues: i.e., how much food was available, how good it 
168 
was, and how easy it was to obtain. Stunkard suggests that these 
stimulus-bound people must make conscious choices about eating, rather 
than relying on an unconscious, internal regulation which for some reason 
19 8 
does not function properly. Clearly this is not incompatible with 
theories of an hypothalamic abnormality. 
Psychiatrists have found it difficult to sort out the psychiatric 
problems created by obesity from those leading to obesity. Basically 
there is no direct evidence linking emotional factors to increased food 
204 
consumption and obesity. However, psychological theories of obesity 
abound. Freud saw it as a regression to the oral stage. Brosin expands 
on the symbolic value of obesity: a big body can be viewed as a fortress 
22 
or may stand for a desired pregnancy. Food may become a substitute 
227 
for inadequate parental love and protection , or be used to resolve 

19 
tension. Some have described obesity as an addiction, but as Swanson 
and Dinello point out this results in a real therapeutic dilemma, since 
. , . . . . _ ,203,204 
total abstinence is impractical! 
Sociocultural factors contribute to increased caloric intake in a 
significant way, as has already been mentioned. Ethnic background has 
a major influence on the value attached to body weight, as does socio- 
66 
economic status. As Goldblatt et al state. 
"It is now apparent that obesity can no longer 
be viewed as simply an abnormal characteristic 
of the individual. It must be viewed as one 
of the possible, and not too infrequent, 
normal responses of persons in certain sub¬ 
groups of society to the perceived expectations 
of their social milieu." (66) 
The relative importance of each of the above-mentioned factors in 
producing an intake inappropriate to energy utilization is impossible to 
determine, and probably varies from case to case. With the exception 
of behavior modification techniques, the therapeutic approach to obesity 
is to ignore the underlying factors and concentrate on correcting the 
positive energy balance. 
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C . MEDICAL MANAGEMENT 
Dieting has been the mainstay of medical management of obesity for 
years. A reasonable goal is to reduce caloric intake sufficiently to 
lose 1-2 pounds per week. One pound of fat is equivalent to 3500 calories 
(fat = 9 cal/g = 4000 cal/lb; however body fat is 15% hydrated). Thus 
a deficit of 1000 calories daily should lead to a weight loss of 2 pounds 
15 
weekly. However the basal metabolic rate decreases as caloric intake 
18 225 
is reduced ’ , and thus a greater reduction in caloric intake may be 
required to sustain comparable rates of weight loss. 
There are innumerable diets: water diets, grapefruit diets, low 
carbohydrate diets, high protein diets. Diet composition is important 
primarily in terms of fluid loss. Subjects on a low carbohydrate diet 
lose more weight in the early stages of dieting than those on a higher 
225 
carbohydrate intake. Water loss accounts for this entire difference. 
The rate of fat loss is comparable in isocaloric diets, irrespective of 
the proportion of carbohydrate, fat or protein in the diet. However a 
disconcerting weight gain due to fluid retention may be seen on changing 
- .. r , . , 78,225,227 
to a diet with a greater amount of carbohydrate. 
In the most important aspect, all diets are alike: they are generally 
unsuccessful. Review of studies of successful weight loss reveals that 
perhaps 25-30% of subjects were able to lose over 20 pounds, and only 
5-8% lost over 40 pounds. The single exception was Feinstein's 
series. He treated 106 patients of varying degrees of obesity with a 
900 calorie formula diet. The regimen included weekly or biweekly follow¬ 
up and an initial lecture to explain the diet. Thirty-five per cent 
quit within 4 weeks, but were included in analysis of the data. Weight 
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loss of over 20 pounds was achieved in 59% of patients, and 31% lost 
over 40 pounds.^ Feinstein attributed the success to the simplicity 
and inflexibility of the diet; however he also believed that psychological 
factors were very important. 
Weight loss can be achieved, albeit in a small proportion of those 
dieting. More important is whether weight loss is maintained. In a 
long-term follow-up of 27 obese patients 14 years after successful weight 
loss, 22 had regained all the lost weight (and 3 of them had put on an 
additional 10% of body weight) while 5 had maintained a weight loss of 
185 
approximately 15% of body weight, although they were still overweight. 
Of 12 patients in Stunkard's series who lost over 20 pounds, only 6 were 
"successful" one year later (they weighed at least 19 pounds less than 
when they started to diet). Two years after the diet, only 2 continued 
to be "successfulWeight maintenance in Feinstein's formula diet 
was typically unsuccessful: of 12 who reached their standard weight, 6 
had regained >_ 30% of the lost weight in one year. From another 36 who 
were able to lose over 30 pounds, follow-up was available on 26. Fourteen 
had regained 30% of the lost weight. This left a total of 18 from the 
group of 106 who were able to maintain a reasonable weight loss for one 
year 
As Bray states, "if there was an effective diet, there would be no 
need for the continuous introduction of new diets," nor for what Mayer 
refers to as the "rhythm method of girth control", i.e., weight loss on 
a diet followed by relapse and another attempt at weight control when a 
18 
new diet is advertised. After concluding that no diet works consistently 
for outpatients, Feinstein analyzed factors leading to successful dieting. 
Differing results for similar diets are largely related to patient 
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motivation and the strength of the doctor-patient relationship."^ 
A number of adjuvants to diet therapy are available. Exercise 
proponents have calculated that one hour of brisk walking uses 350 calo¬ 
ries, and a one hour "work-out" uses 800 calories; thus a daily walk, 
or a work-out four times a week, should result in weight loss of about a 
pound a week.^^ Some worry that exercise increases appetite, but this 
generally is not enough to interfere with weight loss. Exercise is 
useful in improving muscle tone and contributing to a general sense of 
1 7 fi 
well-being. It is an important part of the dietary regimen, but is 
seldom used alone for weight regulation. 
A variety of anorexiant agents have been introduced to assist the 
dieter. A double blind study using a mixture of dextroamphetamine and 
prochlorperazine in obese women concluded that those receiving the drug 
combination experienced a greater weight loss over 6 weeks than those 
receiving placebo and those who did not get any medicine. It is interest¬ 
ing that 69% of those receiving placebo described a decrease in appetite, 
compared to 86% on the active drug, a difference that was not statisti- 
159 
cally significant. Because tolerance to anorexiant drugs develops, 
Silverstone and Solomon designed a double blind trial of diethylpropion, 
a long-acting agent, given daily in alternate months. Controls received 
placebo in alternate months and all were placed on a low carbohydrate 
diet. Only 11 of the original 32 completed a full 12 months trial, and 
182 
there was no significant difference in weight loss between the 2 groups. 
Many people feel that these drugs are of questionable value.-*0»109 
Although they may be useful short-term adjuvants to diet, none of the 
anorexiant agents is helpful in the maintenance of weight loss. All these 
drugs must be used with caution, not only because of their abuse potential. 
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86 
but also because deaths have been reported. 
Hormone therapy, particularly with thyroid, has been suggested to 
help the dieter lose weight. (It should be noted that thyroid function 
is normal in most of the obese. ) Thyroid hormone (either or T^) in 
pharmacologic doses does lead to a temporary weight loss, but the subject 
tends to lose lean body mass rather than fat. Once the hormone is dis¬ 
continued the weight is quickly regained. There are also significant 
risks to treating euthyroid subjects with thyroid, most notably cardiac 
arrhythmias. HCG (human chorionic gonadotropin) as a daily injection 
has been said to have a significant effect on weight loss. Studies have 
7 8 
been poorly controlled, however, with conflicting results. Growth 
160 
hormone has also been used, with equivocal success. It appears that 
weight loss associated with hormone therapy is due to the accompanying 
caloric restriction.^^ 
Group and individual therapies have been used as an adjunct to diet. 
"Weight Watchers" and "Overeaters Anonymous" are informal groups of people 
with weight problems. TOPS ("Take Off Pounds Sensibly") is a similar 
nonprofit organization that uses social pressure to encourage weight loss. 
Weekly meetings center around the weigh-in, in which weight loss or gain 
is announced to the audience, to be greeted by the appropriate applause 
or hisses. There is no controlled study of the TOPS program, but 
apparently if a new member stays (50% drop out within 6 months), he or 
she will lose some weight. Although the group views overweight as an 
emotional problem, most of the individual members avoid mental health 
211 
resources. 
Group therapy led by trained psychiatrists has been no more success¬ 
ful than diet alone in producing weight loss. Buchanan’s study, in fact. 
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demonstrated a weight gain over the first 6 to 9 months, attributed to 
24 
resistance to the exploration of internal conflicts. Most individual 
psychotherapy has concentrated on depressive symptoms that occur during 
dieting and following weight loss, relating this to oral deprivation, 
unresolved tension, or a failure of weight loss to solve all the indi- 
, 65 
vidual s life problems. 
One promising contribution from the behavioralists is the application 
of behavior modification techniques to the problem of weight loss. Over¬ 
eating is the only behavioral characteristic consistently associated 
224 
with obesity. If behavioral disorders are learned responses, then in 
theory these responses can be unlearned: the environment can be modified 
to strengthen "good" eating habits and weaken or extinguish "bad" habits. 
In general, food is removed from all rooms except the kitchen; all food, 
except salad, is kept in an unprepared state (to cut down on compulsive 
eating); eating is made a pure experience, apart from listening to the 
radio or watching TV. In Stuart’s original group of 10, 8 lost over 20 
194 
pounds and 2 lost over 40 pounds. Fifty-three per cent of Penick s 
15 patients lost over 20 pounds, and 13% lost more than 40 pounds. At 
follow-up ranging from 3 to 6 months, 27% had lost more than 40 pounds. 
These results compare favorably to the best series of dietary management 
alone. However numbers are small, and further study is required to fully 
evaluate the success of behavior modification. 
In-hospital fasting and semistarvation diets (300-600 calories/day) 
have been quite successful in producing weight loss. The restricted 
environment generally assures caloric deprivation. On a total fast a 
weight loss of 3/4 to 1 pound per day can be expected.^ This mainly 
represents metabolism of adipose tissue. The body’s carbohydrate stores 
149 
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are so small as to make a negligible contribution to weight loss. Protein 
is lost initially, but protein dissolution progressively declines and 
soon represents only a small portion of the total negative caloric 
balance. Administration of small amounts (200-300 calories) of glu¬ 
cose, L-alanine (a major glucose precursor), or casein has been shown to 
minimize protein loss.^ 
Fluid and electrolyte depletion can be major in the first days of 
fasting or semistarvation, resulting in postural hypotension. Although 
aldosterone and acidosis may contribute to sodium wasting, it is likely 
that other factors are more important. Sigler postulates that sodium 
loss during fasting is obligatory as cation coverage for metabolically 
generated anions (primarily ketoacids). Refeeding with glucose leads to 
a parallel decrease in excretion of sodium and anions. When adaptive 
181 
renal ammonium excretion increases, sodium loss is reduced. Thus 
214 
after the first week of fasting, sodium losses are small. Hypoinsulin- 
emia^ and increases in glucagon"'-^>189 during fasting may also be impor¬ 
tant contributing factors. Potassium is lost in the urine at an initial 
rate of 40-45 mEq/day. Renal adaptation is somewhat more gradual than 
with sodium, and is only partial. A loss of 15-20 mEq potassium per day 
can be expected, leading invariably to depletion of whole body K+ and 
+ | | |- | 
often to a fall in serum K . Losses of Ca and Mg are small and 
19 generally insignificant. 
Ketosis occurs in patients undergoing severe carbohydrate restriction 
or fasting, occasionally leading to mild nausea and an unpleasant taste 
204 203 
in the mouth. * Hyperuricemia always develops as ketoacids compete 
with uric acid for transport by the proximal tubule. With refeeding the 
1 r\ I 
uric acid falls only gradually, even though ketosis disappears rapidly. 
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Most patients tolerate a fast or semistarvation diet well. Supple¬ 
mentation with vitamins, folate, and potassium is routine. Intake of 
noncaloric fluids is encouraged. Patients with a history of gout are 
18 placed on allopurinol. Symptoms are usually confined to the first few 
days of fasting (mild headache, nausea, dizziness) and resolve spontaneously, 
although postural hypotension may persist. Complications do occur, in¬ 
cluding electrolyte imbalance, leukopenia, anemia, renal stones, hair 
loss, and muscle wasting, as well as death on rare occasions (secondary 
to lactic acidosis, muscle depletion, and arrhythmias),101*190 
Success has been equivocal: weight loss occurs consistently, but 
maintenance at the new level rarely lasts long. Swanson and Dinello 
found only 16% "partial success" in a follow-up of 1-50 months in a group 
of fasted patients (56% had regained all the lost weight; 28% were lost 
203 to follow-up). Follow-up by questionnaire in another series of fasted 
patients revealed weight gain in 33% of respondents; 46% continued to 
lose weight, and 21% remained the same. However only half the initial 
subjects returned their questionnaires, and they tended to be ones who 
84 had been most recently discharged from the hospital. MacCuish and 
Munro's intial experience with fasting was discouraging: mean weight loss 
during the fast was 26.7 pounds, and mean weight gain on follow-up 
(averaging 14 months later) was 28.5 pounds. However, 4 of their 23 
106 patients did manage to keep the weight off. Using a more aggressive 
approach, they starved patients down to within 25% of ideal weight. At 
18 months follow-up, 4 of the 12 who reached this goal had regained the 
lost weight, but 8 had maintained the weight loss although they "required 
128 
constant supervision." It is difficult to decide whether such dramatic 
starvation is more beneficial, or if we are only seeing an effect of what 
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Feinstein refers to as the physician's role as watchdog. 
Medical therapy simply does not have much to offer the obese patient. 
Certain groups have a better chance of being successful at a diet — men, 
highly motivated patients, those with adult-onset obesity — but results 
are not very predictable.The problem is that "dieting doesn't cure, 
3 
it must be continued forever." 
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D. SURGERY 
When medical management of obesity fails, a variety of surgical 
procedures can be employed. These include removal of local fat deposits, 
108 
wiring the jaws shut, and major surgery. Two gastric procedures have 
been well described: the gastric bypass, which is a 90% gastric exclusion 
with a retrocolic gastroenterostomy; and the gastroplasty, which divides 
the stomach into a small upper reservoir connected by a narrow channel 
to the bulk of the stomach. In both procedures the small gastric chamber 
leads to early satiety and a voluntary reduction in intake. Operative 
mortality is 2-5% and complications are few: chiefly stomal ulceration 
in the gastric bypass and obstruction in the gastroplasty. Weight loss 
averaged 100 pounds in the first year post-gastric bypass, according to 
one report.^ Gastroplasty is somewhat less successful, and weight 
loss at one year averages about 50 pounds. The disadvantage of gastric 
surgery is that patients may learn to eat continuously, which completely 
nullifies the procedure. The gastric remnant or upper pouch often di- 
i . . . . 155 lates, requiring revision. 
In more common use is the jejunoileostomy or intestinal bypass. 
There are variations, but all bypass the greater part of the small bowTel 
by anastomosing the proximal jejunum to the terminal ileum. Payne pre¬ 
serves 14 inches of functional jejunum, which he anastomoses end-to-side 
to 4 inches of terminal ileum.Scott uses 12 inches of jejunum and 
6 inches of ileum, which he anastomoses end-to-end; the distal end of the 
bypassed bowel must be drained into the colon.^ (See diagram p.61 .) 
The jejunoileostomy works on the principle of malabsorption due to 
a limited surface area for absorption of foodstuffs. Despite virtually 
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unlimited intake, a person will not gain weight after a bypass.^5 
Weight loss is usually rapid in the first 3 months, and then tapers until 
the weight reaches a plateau around 18 months post-operatively. Most 
patients lose from 80-120 pounds. Other benefits include a decrease in 
cholesterol levels, improvement in diabetes, and in many cases the normal- 
.13 
ization of hypertension. 
Because of a number of complications (particularly hepatic failure, 
but also electrolyte imbalance and intractable diarrhea, arthritis, and 
urinary tract stones), most surgeons have set strict criteria for the 
procedure. In general, jejunoileostomy is reserved for (1) the morbidly 
obese (twice ideal weight or 100 pounds over ideal weight for at least 
5 years), (2) who have failed vigorous medical management, (3) in the 
absence of a correctable endocrinopathy, (4) and with complications of 
their obesity (hypertension, diabetes, Pickwickian syndrome, venous stasis, 
arthritis, inability to properly care for body hygiene), (5) who promise 
52 148 217 27 
to avoid alcohol postoperatively. * ’ ’ Contraindications to the 
procedure include severe cardiovascular disease, recent pulmonary embolus, 
chronic liver failure, absent or incontinent anal sphincter, and acute 
psychiatric disorders (although Weismann states that a psychiatric diag- 
217 20 
nosis is rarely a contraindication). * 
Internists have been extremely wary of the procedure, as are many 
surgeons. Nonetheless, it is estimated that 5,000 jejunoileostomies have 
20 
been performed in the U.S. A recent editorial gave reluctant approval 
to the operation if the above-mentioned stringent criteria are strictly 
applied, and even went so far as to approve the procedure for hospitals 
outside major teaching centers if an internist, surgeon, and psychiatrist 
108 
worked together with each patient. 
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The following is a report of a series of jejunoileostomies performed 
in an 11 bed hospital in rural Montana by a family practitioner who 
served the combined roles of surgeon, internist, and psychiatrist. 

II. NINETY-THREE CASES OF JEJUNOILEOSTOMY: WEIGHT LOSS, CHANGES 
IN BLOOD PRESSURE, AND COMPLICATIONS 
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A. MATERIALS AND METHODS 
Starting with the first jejunoileostomy in 1969, over 90 
intestinal bypass procedures have been done at the Liberty County 
Hospital in Chester, Montana by Dr. R. S. Buker, Jr. Indications 
for surgery have been somewhat looser than the strict criteria employed 
in most studies in the current literature. The major requirement in 
this series was long-standing obesity with a failure of medical 
management to produce weight loss. The definition of obesity was a 
relative one, and involved a consideration of body weight, height, and 
ideal body weight as predicted by insurance company tables. Arbitrary 
figures such as weight greater than 100 pounds over ideal or weight 
twice ideal were not employed. Many patients had complications of their 
obesity (hypertension, diabetes, Pickwickian syndrome, arthritis, 
venous stasis), or had reached the point where they were unable to 
care for their own body hygiene. These were important factors in 
the decision to proceed with surgical therapy. 
Surgical procedure. The operative procedure, identical 
in every instance, consisted of anastomosing ten (10) inches of 
jejunum, measured from the ligament of Treitz, to eight (8) inches of 
ileum, measured from the ileocecal valve, in an end-to-side manner 
(Figure 1). The distal end of jejunum was oversewn and then tacked 
down to the bowel to prevent intussusception. A few changes in 
technique were made after the first cases: (l)Because of a problem 
with herniation through the longitudinal incision, all further cases 
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were performed through a transverse incision above the umbilicus; 
(2) to reduce the number of operative complications and to shorten 
intra-operative time, appendectomies were not routinely performed; 
(3) the abdominal cavity was lavaged with a solution of 500 mg 
kanamycin suspended in 500 cc sterile saline to reduce the incidence 
of wound infections. 
FIGURE 1. Surgical procedure 
Patient population. All patients who underwent jejunoileostomy 
at the Liberty County Hospital from July, 1969 (the first procedure) 
through April, 1976, were included in this study. There were 93 such 
patients. Their ages ranged from 16 to 61 years. Fourteen were male 
and 79 female. Pre-operative weights ranged from 162 to 466 pounds 
(mean 263 + 6). Patients were a mean of 104 + 3% over ideal weight 
(range 45% to 231% over ideal weight). 
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FIGURE 2. Weight prior to jejunoileostomy. 
40 • 
30 - 
20 ' 
10 
0- 
10 
11- 
20 
21- 
30 
31- 
40 
41- 
50 
51- 
60 
61- 
70 
Age (years) 
FIGURE 3. Age at jejunoileostomy. 
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Methods 
(1) Chart review 
A review of the outpatient chart, including discharge 
summary of each local hospitalization, of each of the 93 patients was 
undertaken to assess operative and post-operative complications and 
changes in blood pressure. Blood pressure and weight were recorded 
with each clinic visit (including an initial visit prior to surgery), 
with a few exceptions. Blood pressure was taken with the patient 
seated in the examining room , by an experienced nurse using a standard 
blood pressure cuff, before the patient was seen by a physician. In 
those cases in which the blood pressure measurement was repeated by the 
physician, the lower of the values was used for the purposes of 
this study. Hypertension was defined as systolic pressure exceeding 
140 mm Hg or diastolic pressure exceeding 90 mm Hg. When a single 
borderline reading was available (e.g., 145/90), a patient was 
considered hypertensive if he or she reported a history of hyper¬ 
tension and if review of the in-hospital chart confirmed a consistent 
elevation in blood pressure. Weights recorded in the chart were 
taken with the patient ordinarily dressed, using an office (balance- 
beam) scale. These values were rounded to the nearest pound. Relative 
Patients weight 
weight was defined as X 100. Ideal 
Ideal weight for height 
weight was derived from a standard Metropolitan Insurance Company 
Table, using the mean value for a "medium frame." 
Using serial recordings of blood pressure, pre- and 
post-operative outpatient blood pressures were compared at follow-up 
of 3 weeks, 2-4 months, 6-12 months, and > 12 months. Patients 
taking anti-hypertensive medications were excluded from the analysis. 
Follow-up was available on a total of 62 patients, but because some 
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patients did not keep appointments the number of patients evaluated 
at each interval varied slightly. Using each patient as his own 
control. Student’s paired t-test was applied to changes in systolic 
and diastolic pressures at each follow-up period. Student’s t-test 
for independent means was used to compare the mean change in blood 
pressure between pre-operative normotensive and hypertensive 
patients. In a group of 21 patients who could be followed longi¬ 
tudinally, Student’s paired t-test was used to assess the signifi¬ 
cance of changes in blood pressure from pre-operative levels and 
from blood pressure at 3 weeks post-operatively. 
Pre- and post-operative blood pressures were also 
compared at different levels of absolute and relative weight loss. 
Again, patients on anti-hypertensive medication were excluded, and 
Student’s paired t-test was used to evaluate the significance of the 
observed changes. Mean reduction in blood pressure among those who 
were normotensive pre-operatively was compared with mean reduction 
among those who were hypertensive prior to surgery at each level of 
weight loss, using Student's t-test for independent measures. 
Despite patient education on the potential hazards of 
the surgery, outpatient follow-up was somewhat less than ideal. In 
several cases after one or two clinic visits, patients were lost to 
follow-up entirely. In other instances, because of the distance 
involved, patients saw their local physician for many health - problems 
post-operatively, returning only infrequently to Dr. Buker for 
routine check-ups. Thus the occurrence of late complications as 
assessed by the chart review is probably an underestimation. 
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(2) Questionnaire 
A questionnaire was sent to the 49 patients whose 
surgery had been performed at least 2 years prior to this study. The 
questionnaire (Appendix A) was designed to evaluate the following: 
(1) Current weight, (2) changes in work and marital status, 
(3) complications, and (4) patient satisfaction. Thirty of the 49 
patients returned completed questionnaires; an additional 3 patients 
were interviewed but did not complete questionnaires; 3 patients had 
died; and 13 were lost to follow-up. 
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B. RESULTS 
WEIGHT LOSS 
In almost every case there was an early rapid weight loss 
associated with severe diarrhea. Figure 4 shows the mean weight of 
32 subjects followed for 2 years after surgery. The rapid phase of 
weight loss ended by 4-6 months and weight stabilized around 18 months 
after jejunoileostomy. 
300 
s 
FIGURE 4. Mean weight in patients followed for 2 years 
(N = 32). 
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Information on weight at one year follow-up was available 
from the charts of 45 patients. Mean weight loss at one year was 
79+4 pounds (or 29 + 1% of pre-operative weight). There was a signifi¬ 
cant correlation between pre-operative weight and weight loss at one year 
after surgery (r = 0.70, P< 0.001). Thus patients who weighed more prior 
to surgery could anticipate a greater absolute weight loss. 
Current weight was reported by 29 patients who returned 
questionnaires and by 3 patients who were interviewed. Follow-up in all 
cases was at least 2 years and averaged 3 years, 5 months. In most cases 
weight had already stabilized by 18 months (Figure 4) and underwent only 
minor fluctuations thereafter. Pre-operative weights varied from 196 to 
435 pounds in these 32 people. Current weight ranged from 115 to 296 
pounds. Mean weight loss was 95+6 pounds (or 34 + 2% of pre-operative 
weight). From Figure 5 it can be seen that 6 of the 32 patients (19%) lost 
less than 70 pounds after jejunoileal bypass (weight loss in these 
patients was 39, 40, 40, 52, 53, and 55 pounds). 
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FIGURE 5. Reported weight loss in 32 jejunoileostomy 
patients on long-term follow-up. 
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Nineteen of 30 subjects reported on questionnaire or 
interview that their obesity had begun before puberty (Question: Before 
surgery, when was the last time your weight was "normal"?). Eight had 
obesity beginning after puberty, in "adult" life, and 3 did not 
reply to the question. Pre-operative weight was significantly 
different between these two groups: pre-pubertal obese weighed 290 + 13 
pounds and adult-onset obese weighed 246 + 13 pounds prior to 
surgery (P<0.05). Adult-onset obese patients came to surgery later 
in life (mean age 43+4 years compared to 32+3 years for pre¬ 
pubertal obese patients, P<0.05). Post-operative weight loss did 
not differ significantly between the two groups. 
Four patients out of the entire group of 93 underwent 
revision of the bypass surgery because of inadequate weight loss (4.3%). 
In the first case the patient lost only 8 pounds over the first 3 
post-operative months. On re-exploration it was found that an 
additional loop of ileum had been included in the original anastomosis. 
When this was corrected the patient went on to lose weight satisfac¬ 
torily (124 pounds at last follow-up, 4 years after surgery). In the 
other 3 cases weight loss was 39, 57, and 97 pounds (the latter in a 
woman who weighed 342 pounds prior to surgery). One of these patients 
was lost to follow-up; one had lost 17 pounds when last seen 3 weeks 
after revision; and the third was recuperating from the surgery at the 
time of this study. In each case at surgery hypertrophy and"elongation 
of the remaining functional bowel was found. 
One other case of problematic weight loss was a woman who 
began to gain weight 2 years, 8 months after bypass. Her weight has 
risen steadily since. Although she is at present 88 pounds lighter 
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than her pre-operative weight, her maximum weight loss was 119 pounds. 
BLOOD PRESSURE 
Relative weight and pre-operative blood pressure. A sig¬ 
nificant correlation was found between relative weight before surgery 
and both pre-operative systolic (r = 0.52, P< 0.0001) and diastolic 
(r = 0.24, P < 0.05) blood pressure. When the analysis was restricted 
to women (complete data was available on only 10 men) and broken down 
into groups according to age, the correlation was much less marked 
and in fact was not significant for diastolic pressure (Table 2). In 
young women the correlation persists for systolic pressure, but in 
women over 40 years relative weight is not significantly correlated 
with systolic blood pressure. 
TABLE 2 
Pre-operative blood pressure and 
relative weight in 64 women 
SYSTOLIC 
Age N 
Mean Blood 
Pressure, mm 
Mean Relative 
Weight 
Correlation 
Coefficient P 
16-29 24 146 + 5 205 + 7 0.64 <0.0002 
30-39 22 144 + 5 204 + 7 0.42 <0.05 
40-59 18 161 + 6 202 + 5 0.32 NS 
DIASTOLIC 
16-29 24 92 + 3 205 + 7 0.16 NS 
30-39 22 90 + 3 204 + 7 0.33 NS 
40-59 18 100 + 3 202 + 5 0.27 NS 
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Change in blood pressure after surgery. Changes in blood 
pressure after surgery in 62 patients not on anti-hypertensive medica¬ 
tion are shown in Table 3. As was mentioned previously, the variation 
in the number of patients evaluated at each follow-up interval is due 
to failure of patients to keep routine appointments. Both systolic 
and diastolic blood pressure fell to a significantly greater degree 
in those patients who were hypertensive pre-operatively. Mean weight 
loss and mean follow-up time after surgery were not significantly 
different between pre-operative hypertensives and normotensives at 
3 weeks, 2-4 months, and > 12 months. However at 6-12 months 
follow-up, hypertensives had lost a mean of 78.8 pounds over 9.9 
months while normotensives lost a mean of 62.2 pounds over 8.3 
months (P< 0.05 in both cases). 
Table 3 suggests that there is an initial rapid fall in 
blood pressure post-jejunoileostomy, followed by a more gradual 
decrease over time. However a fairly large number of patients missed 
follow-up at one or more of the intervals used. A group of 21 
patients were each seen at 3 weeks, 6-12 months, and >12 months. 
Table 4 records the mean systolic and diastolic pressures in these 
patients as they were followed over time. Mean weight loss at each 
of the follow-up periods did not differ significantly between the 
normotensive and hypertensive groups. (See Appendix B for BP details). 
Blood pressure fell significantly in both groups, except for 
diastolic pressure in the normotensive group. Hypertensives showed a 
greater drop in blood pressure at 3 weeks follow-up, but from this 
point on the two curves are parallel (Figure 6). When changes in blood 
pressure from the pressure noted at _3 weeks were compared between the 
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two groups at 6-12 months and>12 months, there were no significant 
differences. After 3 weeks, both systolic and diastolic blood 
pressures in pre-operative normotensives and hypertensives changed 
to the same extent. Thus the greater overall reduction in blood 
pressure in pre-operative hypertensives appears to be entirely due 
to a larger early fall in blood pressure. This reduction was 
sufficient to produce a normal mean blood pressure (137.6/81.8) at 
follow-up of over 12 months. 
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TABLE 3 
Mean change in blood pressure with time after surgery 
SYSTOLIC (mm Hg) DIASTOLIC (mm Hg) 
Time post-op: 3 weeks 3 weeks 
All patients followed (47) -13.6+2.6 -7.1+2.3 
Normal BP pre-op (16) 
-5.5+3.1*! +0.5+2.7*i 
P<0.01 P< 0.005 
HBP pre-op (31) -17.7+3.4 -J -10.7+3.0—1 
2-4 months 2-4 months 
All patients followed (50) -19.0+3.2 -10.2+2.4 
Normal BP pre-op (17) -9.6+2.5—I -6.1+3.4*1 
HBP pre-op (33) 
P<0.05 P-NS 
-23.9+4.4—1 -12.3+3.2 _J 
6-12 months 6-12 months 
All patients followed (38) -21.6+4.7 -15.2+2.7 
Normal BP pre-op (8) -9.8+2.8 | -4.5+2.7*1 
P<0.02 P<0.0025 
HBP pre-op (30) -24.8+5.8 —1 -18.1+3.1—1 
12 months 12 months 
All patients followed (31) -27.1+4.5 -18.7+2.9 
Normal BP pre-op (9) -15.8+3.3—] -11.8+4.3 1 
P<0.02 P<0.05 
HBP pre-op (22) -31.7+6.0-1 -21.5+3.5-1 
* Not significantly different from zero by Student's paired t-test. 
All other values significantly different from zero (P<0.05). 
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FIGURE 6. Blood pressure and weight loss in 21 patients 
followed longitudinally after jejunoileostomy (Mean + S.E.M.)* 
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Pre- and post-operative blood pressures were also compared 
at given levels of weight loss (Table 5). Except for values marked 
with an asterisk, change in blood pressure from pre-operative levels 
was statistically significant. Again pre-operative hypertensives 
showed a greater fall in blood pressure. Systolic pressure tended to 
fall more than diastolic. 
Because pre-operative hypertensives were heavier before 
surgery than normotensives were (264 + 7 compared to 229 + 8 pounds, 
P<0.05), change in blood pressure with weight loss was re-examined 
with weight loss expressed as a per cent of initial body weight 
(Table 6). The pattern is very similar to that in Table 5, with 
those who were hypertensive prior to surgery showing a significantly 
greater drop in blood pressure. 
The number of patients who could be followed through all 
levels of weight loss (absolute or relative) was small and precluded 
a longitudinal analysis of change in blood pressure with progressive 
weight loss. However Tables 7 and 8 show that there is a significant 
positive correlation between weight loss (both absolute and relative) 
and change in both systolic and diastolic pressure in patients who 
were hypertensive before surgery. This analysis was done at a 
follow-up of greater than 12 months after surgery (mean 2.2 years), 
by which time weight has begun to stabilize. No relationship could be 
demonstrated between weight loss and change in blood pressure in those 
who were normotensive prior to surgery. 
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TABLE 5 
Mean change in blood pressure with weight loss 
after surgery 
SYSTOLIC (mm Hg) 
Weight Loss: 15-24 pounds 
All patients followed (37) -18.4+2.4 
Normal BP pre-op (14) -13.1+3.31 
P<0.05 
HBP pre-op (23) -21.7+3.1J 
DIASTOLIC (mm Hg) 
15-24 pounds 
-9.9+2.4 
-1.4+4.1*—| 
P<0.005 
-15.0+2.5 -J 
25-34 pounds 25-34 pounds 
All patients followed (32) -13.6+3.4 -3.3+2.5* 
Normal BP pre-op (12) 
HBP pre-op (20) 
-2.8+3.0*1 
P<0.005 
-20.1+4.7 -1 
+0.1+3.3*H 
P-NS 
-5.2+3.5* -1 
35-54 pounds 
All patients followed (32) -18.0+4.9 
Normal BP pre-op (11) -7.1+2.4 ~~| 
P<0.05 
HBP pre-op (21) -23.7+7.0 -1 
35-54 pounds 
-8.3+2.9 
-1.6+4.0*1 
P<0.05 
-11.8+3.7 —I 
55 pounds 
All patients followed (29) -19.4+3.5 
Normal BP pre-op (8) -6.3+4.0*1 
P<0.005 
HBP pre-op (21) -24.5+4.2 —1 
^55 pounds 
-15.8+2.6 
-3.0+2.0*1 
P<0.005 
-20.7+2.8 -1 
* Not significantly different from zero by Student’s paired t-test. 
All other values significantly different from zero (P<0.05). 
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Weight loss (pounds) 
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FIGURE 7. Change in blood pressure with weight loss 
after surgery (Mean + S.E.M.). 
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TABLE 6 
Mean change in blood pressure with weight loss 
(% initial weight) after surgery 
SYSTOLIC (mm Hg) 
Weight loss 
initial weight): 49.9% 
All patients followed (51) 
Normal BP pre-op (18) 
HBP pre-op (33) 
-16.0+2.6 
-8.2+3.in 
P<0.01 
-19.7+3.4J 
DIASTOLIC (mm Hg) 
<9.9% 
-10.0+2.2 
-2.6+3.2* 1 
P<0.005 
-14.1+2.6 —I 
10.0-19.9% 
All patients followed (46) -14.1+3.6 
Normal BP pre-op (18) -6.0+2.6 —r 
P<0.05 
HBP pre-op (28) -19.4+5.5 —1 
10.0-19.9% 
-4.1+2.3* 
-0.5+2.6*1 
P-NS 
-6.4+3.3 —^ 
All patients followed (35) 
Normal BP pre-op (12) 
HBP pre-op (23) 
20.0% 20.0% 
-19.1+3.0 
-8.0+2.9 -| 
P<0.005 
-24.9+3.8 -I 
-15.2+2.3 
-4.7+2.9*1 
P<0.005 
-20.7+2.6 -1 
* Not significantly different from zero by Student's paired t-test. 
All other values significantly different from zero (P 0.05). 
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FIGURE 8. Change in blood pressure with weight loss 
(% initial weight) after surgery (Mean + S.E.M.). 

TABLE 7 
Correlation between absolute weight loss and change in 
blood pressure at > 12 months follow-up 
(mean = 2.2 years) 
Change in Change in 
systolic BP diastolic BP 
All patients followed (31) r = 0.62 r = 0.45 
Normal BP pre-op (9) -0.15* -0.23* 
HBP pre-op (22) 0.68 0.55 
* Not significantly different from zero. 
All other correlation coefficients significant (P<0.005). 
TABLE 8 
Correlation between relative weight loss and change 
in blood pressure at >12 months follow-up 
(mean = 2.2 years) 
All patients followed (31) 
Normal BP pre-op (9) 
HBP pre-op (22) 
Change in 
systolic BP 
r = 0.46 
0.16* 
0.59 
Change in 
diastolic BP 
r = 0.34 
0.02* 
0.48 
* Not significantly different from zero. 
All other correlation coefficients significant (P<0.05). 
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Reversion of hypertension to normal. Of the 49 patients 
whose surgery was performed at least 2 years prior to this study, 34 
were found to be hypertensive pre-operatively. Three of these 34 
subsequently died, and 3 others were lost to follow-up. As the 
remaining 28 hypertensives were followed after bypass, the number 
demonstrating normal blood pressure (<140/90) progressively 
increased. At 8 months after surgery 50% had become normotensive, 
and 18 (64%) were normotensive at final follow-up (Figure 9). Mean 
pre-operative systolic and diastolic blood pressures and mean 
relative weight did not differ significantly between the group that 
remained hypertensive and the group that became normotensive after 
surgery (Table 9). Nor could the two groups be distinguished by pre¬ 
operative weight or post-operative weight loss. Age at surgery, 
however, was lower in the group who subsequently became normotensive 
(33 + 3 years compared to 42 + 3 years, P< 0.05). 
TABLE 9 
Comparison of pre-operative parameters 
Mean Mean Mean 
Systolic BP Diastolic BP Relative Weight 
HBP normalized post-op 172 + 6 mm 106 + 4 mm 218 + 7 
HBP persisted post-op 176 + 9 107 + 3 222 +15 
Since weight loss increases with time post-operatively, 
the relationship between weight loss and normalization of blood 
pressure was examined. Column 1 of Table 10 gives the weight loss at 
which normal blood pressure was first noted in each of those who sub¬ 
sequently remained normotensive. Figure 10 is a graph of the per 
cent normotensive against weight loss. 

FIGURE 9. Per cent of pre-operative hypertensives 
(N-28) remaining hypertensive on long-term follow-up. 
TABLE 10 
Weight loss and blood pressure in 28 hypertensives 
Weight loss 
(pounds)* 
Number 
Normotensive 
Cumulative Per Cent 
Normotensives Normotensive 
0 0 0 0 
15 2 2 7 
22 1 3 11 
23 1 4 14 
27 1 5 18 
30 1 6 21.5 
38 1 7 25 
43 1 8 28.5 
49 2 10 35.5 
57 1 11 39 
78 1 12 43 
83 1 13 46.5 
89 1 14 50 
92 1 15 53.5 
96 1 16 57 
108 1 17 61 
179 1 18 64 
* Weight loss achieved at the time BP first noted to be normal and 
after which no further hypertensive levels were recorded. 

100 54 
80 
Weight loss (pounds) 
FIGURE 10. Weight loss and normalization of blood pressure 
in 28 hypertensive patients. 
An increasing percentage of pre-operative hypertensives became 
normotensive with increasing weight loss up to 100 pounds. Very 
few patients lost more than this amount of weight, and the effect of 
further weight loss on blood pressure cannot be predicted. 
SOCIAL 
Marriage and children. Marital status in 32 patients at least 
two years after bypass surgery was reported as follows: 18 married, 
6 single, 7 divorced, and 1 separated. Five of the marriages, three 
divorces, and the single separation occurred after jejunoileostomy. 
Two women had children after surgery. This was the second child 
for one of them. The other woman was a 19 year old who was nulliparous 
at the time of surgery. 
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Work. A total of 8 of the 29 patients who completed 
questionnaires stated that they had been on Welfare at some time. 
Five patients were Welfare recipients pre-operatively. After surgery 
3 of these 5 no longer received Welfare benefits; however an additional 
3 patients went onto Welfare after surgery. Thus the number of patients 
on Welfare pre- and post-operatively was identical. 
Job status was assessed from the questionnaire. Most 
patients did not report their salaries, so that changes in employment 
cited below refer to full versus part-time work or unemployment. 
Twenty-two patients resumed their former level of employment after 
surgery (only one of them remained unemployed to a degree unexplained 
by age, physical disability, or household duties). Another 5 patients 
actually worked more after surgery, moving either from unemployment 
to a part or full-time job, or from part-time to full-time employment. 
Finally 2 patients were working less after surgery than before. One 
of these was "not able to hold a job, since I get ill and I am not 
able to function properly." This woman was on Welfare at the time 
of follow-up. A second woman, who was 20 years old, was only working 
part-time, although she had worked full-time for the first post¬ 
operative year. 
COMPLICATIONS 
Mortality. There have been a total of 4 deaths out of the 
group of 93 patients (4.3%). One was related to a technical error, 
i.e., the bowel was perforated by a misplaced clamp. Clinically this 
patient became hypotensive on the second post-operative day, passed 
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bright red blood per rectum, and despite transfusions died before 
re-exploration was possible. The other 3 deaths occurred suddenly, 
within one month of surgery. H.S., a 60 year old insulin-dependent 
diabetic with hypertension, developed dyspnea and a cough post- 
operatively, which led to wound dehiscence. After operative repair 
he became increasingly dyspneic and cyanotic and suffered a cardiac 
arrest on the fifth post-operative day. E.J., a 61 year old with 
hypertension and a history of thrombophlebitis, required oxygen 
post-operatively to keep her P within a reasonable range. She was 
°2 
able to progress rapidly to a regular diet, however, and was discharged 
on the eighth post-operative day. She died suddenly at home several 
days later. B.W. , a 466 pound hypertensive, underwent re-exploration 
for a malfunctioning bypass on the eighth post-operative day; the 
anastomosis had been improperly formed and was revised. He developed 
a wound infection and then hepatitis, but recovered uneventfully, 
only to die suddenly one month after the original procedure. No 
autopsy material was available on any of the last three cases; 
clinically death was attributed to pulmonary embolization or 
myocardial infarction. 
Morbidity. Short and long term complications among the 
93 subjects are recorded in Table 11. This data was derived from the 
chart review and supplemented where appropriate with information from 
the questionnaires. Because a number of patients did not return for 
routine follow-up, complications have probably been underestimated. 
Four of the 93 bypasses performed were revised because of 
inadequate weight loss, as mentioned previously. A single patient 
had her bypass taken down. She stated that she had been terribly 

57 
sick for a year, requiring hospitalization for "kidney trouble," On 
the advice of her personal physician she had the bypass reconnected 
at another hospital. 
Patients responding to the questionnaire reported a number 
of symptoms after jejunoileostomy. Most of these were gastrointestinal, 
but there were also frequent complaints of dizziness, weakness, and 
muscle cramps. Half the subjects noticed hair loss after the surgery. 
Three patients stated that they had been bothered by gallstones 
post-operatively, and two reported anemia (undocumented). 
TABLE 1.1 
COMPLICATIONS IN 93 PATIENTS POST-JEJUNOILEOSTOMY 
Wound infections 
Hepatitis 
Metabolic (Hypokalemia or 
hypocalcemia requiring 
in-hospital treatment) 
Urinary tract stones 
Obstruction 2° adhesions 
Abdominal pain, unknown 
etiology 
Acute colonic distension 
Ventral hernia 
6 (6.4%) 
2* (2.1%) 
2 (2.1%) 
3+ (3.2%) 
1# (1%) 
2 (2.1%) 
1 (1%) 
7+ (7.5%) 
* One patient died suddenly after recovering from 
hepatitis 
+ One CaP04 (negative for oxalate); one reported as 
Ca; one not retrieved. 
# Node at exploration revealed regional enteritis. 
+2/7 were recurrences. 
TABLE 12 
SYMPTOMS REPORTED BY 30 PATIENTS AFTER BYPASS SURGERY 
Diarrhea 27 (90%) Muscle cramps 7 (23%) 
Bloating 22 (73%) Joint pains 6 (20%) 
Abdominal Dizziness 9 (30%) 
cramps 14 (47%) Weak spells 8 (27%) 
Vomiting 5 (17%) Hair loss 15 (50%) 
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In response to the question, "Have you been under a doctor's care 
for any medical problems since your operation?", the following were reported 
TABLE 13 
MEDICAL PROBLEMS SINCE SURGERY IN 30 PATIENTS 
Diabetes 1 (3%) 
Kidney stone 
Hernia/ 
2 (7%) 
lipectomy 3 (10%) 
Electrolytes 1 (3%) 
Phlebitis 1 (3%) 
Ob / Gy n 7 (23%) 
Thyroid 2* (7%) 
Gallbladder 1 (3%) 
Fluid 
retention 2 (7%) 
Gout/ 
arthritis 3 (10%) 
Other 4// (13%) 
* one thyroidectomy; one thyroiditis. 
# automobile accident, UTI, "stomach trouble," unspecified renal disease. 
Twelve of the 30 patients denied taking any medications on a daily 
basis. Ten took vitamins and/or minerals daily; 2 were taking calcium 
and 3 potassium; 4 were using diuretics. A few other drugs were 
mentioned as being used regularly, including "Mylicon" and "Colbenemid." 
PATIENT SATISFACTION 
When asked, "If you had to do it all over again, would 
you have this operation for your weight problem?", replies were as 
follows: 23 Definitely yes, 3 Probably yes, 3 Probably no, and 1 
Definitely no. There was no trend in terms of weight loss or the 
number of complications noted on the questionnaire. The single patient 
who had her anastomosis taken down answered the question with 
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"probably no." In general patients were ecstatic about the weight 
loss and enthusiastic about the surgery. Appendix C contains excerpts 
from the comments made by subjects completing the questionnaire. 

III. DISCUSSION 
JEJUNOILEOSTOMY 
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A. BENEFITS 
On the basis of studies in dogs, Kremen was the first to suggest 
that obesity might be treated by "removing from intestinal continuity 
sufficient small bowel to produce weight loss without any other serious 
,.100 
hazard or impairment. He actually performed a jejunoileostomy for 
this purpose almost 10 years before Payne's first jejunocolic shunt. 
Payne abandoned the jejunocolic shunt because of severe metabolic compli¬ 
cations and high mortality. Part of his original study design was to 
take down the anastomosis once a satisfactory weight was reached. In 
early cases he discovered that the weight was quickly regained. This 
led him to revise the jejunocolic shunt to a jejunoileal anastomosis. 
He found that weight was regained with as little as 35 inches of bowel 
147 
in functional continuity. Thus he adopted a more radical bypass, 
anastomosing 14 inches of jejunum end-to-side to 4 inches of ileum. This 
procedure preserved the ileocecal valve and the bile acid and B ab- 
sorptive surface of the terminal ileum. 171 Scott, citing inade¬ 
quate weight loss due to reflux of intestinal contents into the bypassed 
loop of bowel, began a trial of the end-to-end bypass. He retained 12 
inches of both jejunum and ileum, later reducing the length of ileum to 
6 inches. The distal end of the bypassed bowel was drained into the 
173 
colon. These are the two basic types of jejunoileostomy, on which 
individual surgeons have imposed minor variations. 
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FIGURE 11. End-to-side and end-to-end variations of 
jejunoileostomy. 
WEIGHT LOSS 
In terms of weight loss, the critical factor is the length of func¬ 
tioning intestine. If over 25 inches of intestine are left in continuity, 
20 108 
weight loss will be slow. ’ Scott and others have found a faster 
weight loss in those with shorter anastomoses. >^17 Although malabsorp¬ 
tion is a major factor in producing weight loss, caloric restriction 
is also important. Because eating exacerbates diarrhea and indigestion, 
12 7 
many patients voluntarily limit their intake. 
There is an early phase of rapid weight loss that lasts 1-3 weeks. 
This corresponds to about 10% of the pre-operative weight and is thought 
72 to be largely body water. A second phase of constant weight loss 
follows. Salmon demonstrated a significant correlation between the rate 
of weight loss and initial weight. Others have found the duration 
72 
of weight loss to be dependent on initial weight. As in previous 
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69 
reports , initial weight in this study correlated with weight loss at 
one year (r = 0.70, p < 0.001). Basal metabolic rate increases with 
increasing obesity"^, and since absorption is fixed by the bypass pro¬ 
cedure, those who are heavier will have a greater caloric deficit and 
will lose more weight. 
Absolute weight loss varies from individual to individual and from 
series to series (Table 14). It is surprising that detailed information 
on initial weight and weight loss is not available in more of the case 
reports in the literature. Payne reports a mean weight loss of 97 pounds 
at one year and 110 pounds at two years after 14+4 end-to-side bypass. 
Average pre-operative weight was 308 pounds. Benfield's patients had 
lost a mean of 96 pounds after 6 months. Pre-operative weight in this 
20 group averaged 348 pounds. In the present study weight loss was some¬ 
what less impressive, averaging 79 pounds at one year follow-up and 95 
pounds at follow-up of over two years. (The latter figure if anything 
overestimates weight loss, since it is derived from the current weight 
reported by 32 subjects. No information is available on weights of 
patients who did not respond to the questionnaire.) However patients 
in this series weighed considerably less than those in either of the 
above groups. Average pre-operative weight of all 93 patients was 263 
pounds, and the 49 patients followed for over 2 years weighed a mean of 
280 pounds. Since weight loss after surgery is correlated with initial 
weight, it appears that this would account for the discrepancy. 
In general, weight loss continues for 12-18 months before leveling 
off. Buchwald found that 90% of his patients came within 50 pounds of 
2 8 ideal weight. Two-thirds of Salmon's patients (also end-to-end 
anastomoses) came within 20 pounds of ideal weight by 1-3 years after 
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TABLE 14 
Type of jejunoileostomy and weight loss 
Procedure Mean initial Mean weight 
Series end-end end-side N weight (pounds) loss (pounds) 
Scott^^ 12+12* 
12+ 6 
12 
50 (240-486) No data 
C 1 165 Salmon 10+20 120 (180-390) No data 
„ - ,28 
Buchwald 16+1.6 94 290 33% below 
pre-op (?time) 
.52 
Fikri 14+ 4 52 (110-240 
over ideal) 
95 (1 year) 
130 (2 years) 
Weismann^^ 15+5 + 
14+4 133 
(50->200 
over ideal) 
101 (> 1 year) 
130 (>1 year) 
Jewell*^ 10+10 
10+12 
15+5 
14+4 
52 314 (e-e)© 
294 (e-s) No data 
p 148 Payne 14+4 
15+5 140 308 
97 (1 year) 
110 (2 years) 
20 
Benfield 16+ 4 16+4 30 348 96 (6 months) 
156 (2 years) 
191 Starkloff 12+ 8 14+4 475 (>125 over 
ideal) 
103 (>1 year, 
e-s) 
PRESENT 10+8 93 263+6 79+4 (1 year) 
SERIES 95+6 (>2 years) 
* 12+12 refers to 12 inches jejunum anastomosed to 12 inches 
terminal ileum. 
® "e-e" stands for "end-to-end" and "e-s" for "end-to-side" . 
number of other combinations were used in this study in 
small numbers. 
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surgery. 
165 Weight stabilizes because of adaptation of the bowel. The 
functioning segment becomes hyperplastic, elongates, and dilates, pre- 
173 
senting a larger surface area for absorption. None of Payne's 
146 
original 58 patients plateaued at a weight below ideal. However at 
times weight does not even approach ideal. Inadequate weight loss 
87 (defined by Jewell as less than 5 pounds/month/year and by Starkloff 
as stabilization at a level more than 50 pounds over "anticipated normal 
weight"^'*') occurs in up to 15% of cases. In this series, 19% of 32 
patients had lost less than 70 pounds on long-term follow-up. However 
2 of these 6 patients were within 50 pounds of ideal weight. Inadequate 
weight loss in patients with end-to-side bypasses is primarily due 
to reflux into the bypassed segment of bowel.The incidence of 
inadequate weight loss is much lower in end-to-end anastomoses: neither 
Scott nor Buchwald reported weight loss under 80 pounds; Salmon mentions 
only 2 cases in his series of 120 in which the procedure was a failure in 
175 28 165 
terms of weight loss. * * (It should be noted that Salmon left 
30 inches of bowel in continuity, which is more than the length recom¬ 
mended for optimal weight loss.) When faced with poor weight loss, many 
surgeons will revise or shorten the bypass. Incidence of such revisions, 
performed only for inadequate weight loss, is shown in Table 15. 
Anywhere from 4 to 10% of end-to-side procedures are revised for 
inadequate weight loss. In the present series a comparable number of 
revisions were performed (4.4%). Revision is only rarely required for 
end-to-end bypass, except when a lengthy segment of bowel is left 
in continuity. 
One patient in the Montana series was beginning to regain weight 2 
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TABLE 15 
BYPASS REVISIONS FOR INADEQUATE WEIGHT LOSS 
END-TO-END REVISIONS (%) END-TO-SIDE REVISIONS (%) 
Scott(175) 0/ 62 Payne (148) 16/165+ (9.7%) 
Salmon(165) 2/113* (1.8%) Weismann(217) 5/12 3x (4%) 
Jewell(87) 1/ 17+ (6%) Benfield(20) 2/ 30 (6.7%) 
Buchwald(28) 0/ 94 Starkloff(191) 13/273 (5%) 
* 10+20 revised to 10+10 
+ in a 12+12 end-to-end jejunoileostomy 
+ 12 underwent resection of elongated bowel; 4 were changed from end-to- 
side to end-to-end. 
x an additional 2 referred from another hospital underwent revision. 
years, 8 months after bypass. She may have developed reflux or extensive 
adaptation of the functioning bowel. As adaptation occurs, GI distress 
diminishes and patients may increase their intake. Fikri has reported a 
similar weight gain of 15-30 pounds in 3 of his 52 patients several years 
52 
after end-to-end bypass. The incidence of such late malfunction of the 
jejunoileostomy is not known, and the question of whether the weight loss 
induced by jejunoileostomy is permanent is a valid one. 
HYPERTENSION 
As was mentioned previously, hypertension is more common in the 
obese. In the Framingham study only a modest correlation was found 
91 between relative weight and systolic blood pressure (r = 0.3). A 
somewhat larger correlation was demonstrated in this series of obese 
subjects (r = 0.52). Differences between the populations involved were 
important, since the Framingham Study consisted of a large adult popula¬ 
tion while the present group is composed of the extremely obese. 
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particularly obese women. Since the Framingham Study showed that both 
91 blood pressure and weight increase with age in women , the correlation 
coefficient was recalculated grouping women subjects by age. A smaller 
correlation was noted, which was only significant in the age 16-29 and 
30-39 groups. It would seem then that relative weight is more important 
with regard to systolic blood pressure in women under 40; from 40 on, age 
and other factors may play a larger role. 
35,99,112,117 
Weight loss has a favorable effect on blood pressure 140,154 
(Table 16). This was noted already in 1923 when Preble followed 194 
subjects who were overweight and found that both systolic and diastolic 
pressures fell with weight loss. He did not separate his group into 
normotensives and hypertensives, but in a separate study he suggested 
that fall in BP is more dramatic in severe hypertensives.'*'"^ Similarly 
Terry's study of obese women with hypertension showed a drop in blood 
206 
pressure with weight loss. Martin compared changes in blood pressure 
in obese normotensives and hypertensives who lost weight. Although obese 
normotensives lost more weight, blood pressure fell to a greater degree 
in obese hypertensives. Martin did not consider a change in blood pres¬ 
sure significant unless the systolic changed by at least 20 mm. Hg or the 
diastolic by 15 mm. Hg. He concluded that weight loss exerted a minor 
effect on blood pressure, although on the average systolic pressure fell 
112 
by almost 16 points in his obese hypertensives. 
Fletcher's careful study of changes in blood pressure in obese hyper¬ 
tensive and normotensive women on a weight-reducing diet is particuarly 
pertinent to this report. He defined systolic hypertension as a systolic 
pressure over 150 mm. Hg, and diastolic hypertension as a diastolic pres¬ 
sure over 90. Systolic blood pressure fell by a mean of 32.8 mm. in women 
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with systolic hypertension who lost an average of 32 pounds, and by 10.8 mm. 
in normotensive women who lost a mean of 30 pounds. Women with systolic 
hypertension who did not lose weight had essentially no change in systolic 
pressure. Similarly, diastolic blood pressure fell by a mean of 16.5 mm. 
in women with diastolic hypertension who lost an average of 33 pounds, and 
by 3.5 mm. in normotensive women who lost an average of 30 pounds. Again 
hypertensive women who did not lose weight showed no change in diastolic 
pressure. Arm girth decreased by a mean of 3.5 cm. +1.8 cm. (s.d.) in a 
combined group of hypertensive and normotensive women who lost weight. 
Separate figures for each subgroup were not reported. Fletcher suggested 
that the fall in blood pressure in normotensive women who lost weight was 
due to a change in arm girth and that hypertensive women who lost weight 
experienced a true fall in blood pressure over and above the error due 
5 3 to arm girth. 
Reports of change in blood pressure following intestinal bypass 
surgery have been much less elaborate, but it is clear that blood pressure 
in hypertensives falls after bypass. Fikri found that 11 of 20 hyper¬ 
tensives became normotensive post-operatively, and an additional 8 experi- 
52 
enced an improvement in their hypertension. All 8 of Payne's hyper¬ 
tensive patients who underwent jejunocolic shunts became normotensive 
147 
on follow-up. Seventy-five per cent of Buchwald's 94 cases had hyper¬ 
tension pre-op (systolic > 140 and/or diastolic > 90). After bypass he 
states that "nearly all had a significant decrease in blood pressure" and 
2 8 
"many became normotensive." None of these studies has reported 
longitudinal follow-up of blood pressure, nor have they considered changes 
in blood pressure at different levels of weight loss post-op. Emphasis 
has been on blood pressure changes in the hypertensive patient, without 
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mention of changes in normotensive subjects. 
The current study demonstrates that blood pressure falls significantly 
in both hypertensive and normotensive patients after 10+8 end-to-side je- 
junoileostomy for morbid obesity. Both systolic and diastolic blood 
pressure fell to a greater degree in patients who were hypertensive prior 
to surgery than in those who were normotensive. A marked early decline 
in blood pressure in hypertensives appears to account for the entire dif- 
72 ference. Weight loss at 3 weeks (the bulk of which is fluid ) averaged 
only 17 pounds in hypertensive subjects. After 3 weeks blood pressure 
continued to decline gradually and to the same degree in pre-operative 
hypertensives and normotensives (Figure 6). 
Dahl postulated that a decreased sodium intake, rather then weight 
loss per se, was responsible for the early reduction in blood pressure 
in obese hypertensives on low calorie diets. He hypothesized that obese 
hypertensives were more sensitive to sodium ingestion and restriction 
41 than were lean hypertensives. The results of the present study suggest 
the possibility that obese hypertensives might be more sensitive to changes 
in fluid and/or salt balance than obese normotensives. Although the 
difference in blood pressure changes between obese hypertensives and normo¬ 
tensives has been noted before in patients losing weight by dieting'*'^’"'’ , 
it has not previously been suggested that this is due to a larger early 
fall in blood pressure in hypertensives. Earlier studies have not examined 
longitudinal changes in blood pressure. Rather they have compared blood 
pressure before and after a given time interval or degree of weight loss. 
Thus these investigations may not have detected the rapid early fall in 
blood pressure that was seen in the present series. It is not known 
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whether the more gradual, late change in blood pressure observed in this 
study is mediated through a prolonged effect of volume and sodium deple¬ 
tion on the baroreceptors or through some effect induced by weight loss 
., . lf 19,183 
or the bypass surgery itself. 
When pre-operative hypertensives and normotensives were examined 
at different levels of weight loss (either expressed in absolute terms 
or as a per cent of initial weight), hypertensives again showed a greater 
fall in systolic and diastolic blood pressure. There appeared to be a 
tendency for blood pressure in pre-op hypertensives to fall further with 
increasing weight loss (Tables 5 and 6). However composition of the 
groups at different levels of weight loss differed slightly. Since it was 
not possible to follow a sufficiently large group of patients longitudi¬ 
nally, one cannot definitely conclude that blood pressure declines directly 
with increasing weight loss after surgery. However the data suggest a 
relationship, since on long-term follow-up a significant correlation was 
found between weight loss (both absolute and relative) and change in 
blood pressure in the hypertensive group. These figures were quite similar 
to the correlation coefficients Fletcher found in obese hypertensive 
53 
and normotensive women who lost weight. In the present study no corre¬ 
lation could be demonstrated between weight loss and change in blood 
pressure in pre-operative normotensives. 
When the group of pre-op hypertensives was studied in detail, it 
was found that 18/28 (64%) became normotensive on long-term fallow-up. 
Three of the 10 who remained hypertensive showed improvement in their blood 
pressure. Weight loss was not significantly different between those who 
remained hypertensive and those who became normotensive, nor did the two 
groups differ in several other pre-operative parameters. However mean 
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age of the group whose blood pressure reverted to normal was almost ten 
years lower than the mean age of subjects whose hypertension persisted. 
It may be that older patients had hypertension of longer duration that 
was more resistant to changes occurring after bypass. Or it is conceivable 
that there are different subtypes of hypertension in obese subjects. 
Because a number of hypertensive patients became normotensive within a 
few months of surgery, the effect of weight loss was examined (Table 10). 
A linear regression was fitted to the data graphed in Figure 10, and the 
following formula was derived: 
Y = 2.0 + 0.56 X 
where X = weight loss in pounds, 0 £X 108 
Y = % normotensive at weight loss of X pounds 
According to this equation, half of those who were hypertensive pre-op 
would be normotensive on reaching a weight loss of 85 pounds. A weight loss 
of 175 pounds satisfies the equation for Y = 100%. However extrapolation 
beyond a weight loss of 90-100 pounds is not accurate because of the 
small number of patients who achieved this degree of weight loss. It is 
impossible to predict what effect further weight loss would have on blood 
pressure, particularly since age seems to play a role. 
Blood pressure readings in this study were drawn from the outpatient 
charts of obese subjects. All had been taken by an experienced nurse, 
and the proportion of readings ending in an integer other than 0 or 5 
suggests that they were recorded with care. It was not possible to 
average several BP readings at each visit, since BP was often taken only 
once. When 2 values were recorded during the same outpatient visit, 
the lower one was used for the purposes of this study. Subjects with 
borderline blood pressure readings were considered hypertensive only if 

72 
they reported a history of hypertension and if the hospital chart confirmed 
a consistent elevation of blood pressure. Both of these methods would 
tend to place hypertensive patients in the normotensive category. 
Two extraneous factors could have been elevating the pre-operative 
blood pressure: (1) tension surrounding the up-coming surgery; and (2) a 
"cuff artifact." The tension factor cannot be excluded by the available 
data, since blood pressure readings weeks or even months before surgery 
were not recorded. However, the differences between hypertensives and 
normotensives cannot be explained by anxiety unless one postulates that 
hypertensives are more responsive to stress. Although weight loss may be 
53 
unmasking a cuff artifact as Fletcher suggests , blood pressure fell 
before sufficient weight loss had occurred to affect arm girth. Further¬ 
more, cuff artifact cannot explain the greater early fall in blood pressure 
seen in pre-operative hypertensives. It is possible that the gradual 
late change in blood pressure observed in this study in both hypertensive 
and normotensive patients was due to the unmasking of such a cuff arti¬ 
fact. Some studies have shown a spontaneous fall in the blood pressure 
of hypertensives over lengthy follow-up (6-9 years), and it is conceivable 
that this contributed to late changes in blood pressure in the present 
76,192 
study. 
OTHER MEDICAL BENEFITS 
Jejunoileostomy has a beneficial effect on other risk factors asso¬ 
ciated with obesity. The following is a brief summary of the changes seen 
in cholesterol, triglycerides, and glucose intolerance following bypass 
surgery, although data in the present series did not include these factors. 
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25 
Buchwald was among the first to note that patients who underwent 
major ileal resection (ileal bypass) had a decrease in plasma cholesterol. 
This procedure is slightly different from the jejunoileostomy — specifi¬ 
cally, the terminal ileum is excluded — but the basic principles leading 
to a lowered cholesterol apply to both procedures. Not only is less cho¬ 
lesterol absorbed (absorption takes place preferentially through the 
distal small bowel), but interference with the enterohepatic circulation 
leads to an increased production of bile acids from cholesterol in the 
liver, thereby increasing cholesterol turnover. Triglyceride levels also 
27 
fall, partly because of changes in carbohydrate intake. In all studied 
patients post-jejunoileostomy, both cholesterol and triglycerides have 
decreased significantly. In one report cholesterol declined by 40% and 
O O 
triglycerides by 50%. Ten of 12 patients with Type IV hyperlipidemia 
in Scott’s series had normal lipid profiles after bypass. Because the 
literature is consistent on this point, cholesterol and triglycerides 
were not routinely measured before and after bypass in the present study. 
As the risk of coronary heart disease increases exponentially with rising 
173 
cholesterol, a lowered cholesterol may be of benefit. 
The insulin resistance and glucose intolerance of the obese has 
already been mentioned. After bypass, the glucose tolerance test tends 
to normalize. More importantly, frank diabetes becomes easier to 
control. Of Fikri's 5 diabetics, 2 no longer required medication and 3 
52 - 28 
needed less insulin post-operatively. Buchwald reports similar findings. 
146 
This has been attributed to diminished glucose absorption ; however, 
the role of increased insulin sensitivity associated with loss of adipose 
48 tissue is probably of greater importance. 
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PSYCHOSOCIAL 
As discussed previously, there are no distinctive behavioral abnor¬ 
malities associated with obesity other than overeating. Dieters experi¬ 
ence a remarkable number of symptoms —weakness, "nervousness," nausea— 
most of which are attributed to oral deprivation and the stress of con- 
186 
tinually resisting temptation. Stunkard has described a more serious 
196 depressive syndrome. In the light of these findings it is important 
to assess the psychological changes in patients post-jejunoileostomy. 
Solow, in a major evaluation of 29 patients, found a significant improve¬ 
ment in depression, self-esteem, and body cathexis post-bypass. Patients 
were more active, reported interpersonal relationships as more satisfying, 
and demonstrated increased self-assertiveness. Six of his 29 patients 
had some type of psychiatric illness during follow-up, which he related 
to previous psychiatric problems. He found that the degree of weight loss 
186 
was related to decrease in depression and improved ego strength. 
Most investigators have not been able to document any substitute 
symptoms appearing with weight reduction in these patients, but several 
have noted an increase in "emotionality," with more anxiety, depression, 
20 
and irritability. One psychiatrist reported that 40 of the 65 patients 
32 
he was following required psychotherapy for "anxiety and depression." 
Scott states that depression is common in the early post-operative months. 
Both Bray and Solow noted a decrease in denial after weight loss, which 
175 
20,186 
they thought was important in terms of the number of symptoms reported. 
In the current series, very few emotional problems were observed post¬ 
bypass. Patients were generally very pleased with the change in their 
life-style. In interviews several confided that they felt like different 
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people, and that this had placed some stress on old dependent relation¬ 
ships. 
Another psychological change seen after intestinal bypass is rever- 
on 1 nf. 
sal of the body image distortion. * This is most notable in attitudes 
toward others: "A recurrent theme among bypass patients was increasing 
32 
reluctance to mingle with fat people." Similarly, in the present 
series one woman being interviewed stated flatly, "I cannot stand fat 
people." Another wondered why they (obese people) didn't cover up more. 
Most reports of jejunoileostomy have included a short statement to 
the effect that most (if not all) patients returned to their former con¬ 
structive employment or became employable because of the weight loss. 
Buchwald found that the rate of "gainful employment" increased in his 
2 8 
series of patients after weight reduction. One editorial states 
"...the procedure appears to have a good record for rehabilitation of 
202 
these unfortunate people back to a useful active life." Some states 
have even been willing to pay for jejunoileostomy because of its success 
in getting patients off Welfare. 
The present study casts some doubt on the role of jejunoileostomy 
in economic rehabilitation. Although work records are difficult to quan¬ 
titate, it was found that employment did not change drastically after 
weight loss. The number of subjects on Welfare before and after surgery 
remained the same. The jejunoileostomy patients had a remarkably poor 
record of paying their hospital bills compared to other surgical patients 
at Liberty County Hospital. One woman received her insurance company's 
check and promptly spent it on a new wardrobe. 
It is possible that the economic situation across the country has 
prevented a complete "rehabilitation" of these people. However it is 
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equally likely that the Montana series, which was much less selective 
than reports in the literature, contained a larger proportion of the 
unmotivated and/or unemployable. That this is true to some extent (with 
regard to motivation) can be seen from the poor follow-up record of most 
of these patients, despite emphasis on the importance of periodic check¬ 
ups and the seriousness of complications. This has important implications 
in terms of a broad application of the jejunoileostomy: motivation is 
critical if adequate follow-up and appropriate management of complications 
is to be achieved. 
- 
77 
B. EARLY COMPLICATIONS 
Mortality. Mortality rate (bypass-related) in large reported series 
varies from 0.7% to 8%. In reviewing 989 bypass procedures, Bray found 
42 deaths either within 1 month of surgery (any cause) or any time there¬ 
after (directly related to surgery), an incidence of 4%. The most fre¬ 
quent cause of death was liver failure, followed closely by pulmonary 
20 
embolism and surgical (technical) problems. The operative mortality 
of 4.4% in the present series compares favorably with these figures. 
It is important to emphasize that this surgery was performed in a small 
hospital; anesthesia was administered by a nurse-anesthetist; and no 
volume respirator was available for those with post-operative respiratory 
insufficiency. Patients were encouraged to ambulate in the first 24 hours 
(in many, use of a bedpan was impossible, and early ambulation was a 
necessity). 
Wound infections. Wound infections are reported in various manners: 
"seromasM or serous drainage, "superficial" wound infection, dehiscence, 
evisceration. Incidence of all wound infections has ranged from 3.3% to 
20 35%. Serous drainage makes up a large proportion of this figure. The 
incidence of wound infections in the present series (6.4%) corresponds 
to that reported elsewhere. Dehiscence occurred in 2 patients, one of 
whom later died. Since wound infections occur in the early post-operative 
period, all these patients were seen at the Liberty County Hospital and 
this figure can be considered very accurate. 
Diarrhea. Virtually 100% of bypass patients have diarrhea for the 
first few months post-operatively. One must suspect an inadequate bypass 
in those who do not. Severity of the diarrhea varies from 6 to 30 liquid 
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to semi-liquid bowel movements per day, and is exacerbated by excessive 
9 g 
liquid or fat intake and by binge eating." Transit time is rapid in 
the early post-operative months, and steatorrhea develops, but even the 
combination of these two factors is not sufficient to account for the 
degree of diarrhea seen. Because water and electrolyte loss may be 
103 
greater than intake , it is postulated that some compound is irritating 
the colonic mucosa, leading to a net secretion. Free fatty acids (soaps) 
or bile acids could produce such an effect. 
Because of the rapid transit time and malabsorption in bypass pa¬ 
tients, free fatty acids pass unabsorbed into the large intestine. Fatty 
acids have been shown to increase colonic secretion, possibly because of 
their detergent action on cell membranes. Post-bypass patients with 
diarrhea have been treated with CaCO^ on the hypothesis that precipitation 
103 
with calcium would decrease fatty acid availability. Their diarrhea 
does improve — stools become pasty or semi-solid. However it is not 
clear that this improvement can be attributed to precipitation of fatty 
acids, since the glycine conjugates of bile acids are also bound by 
79 
calcium. Bile acids (regardless of the state of conjugation) are known 
to cause a reversible secretion of water and electrolytes into the lumen 
of the colon in the absence of any morphological damage. Hofmann and 
Poley demonstrated that a resin such as cholestyramine could decrease 
diarrhea in many patients after ileal resection. They postulated that 
79 
resin binding of bile acids was the underlying mechanism. At present 
it has not been determined whether fatty acids or bile acids do in fact 
contribute to the excessive diarrhea. 
Most patients require narcotics to control diarrhea for the first 
few months after surgery, but the dose can be tapered and eventually 
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13 217 discontinued. * Experience has shown that a bland, fat-free diet 
avoiding raw vegetables and roughage is also helpful. Patients are 
advised to take small amounts of liquids frequently. Careful perianal 
skin care is important, as hemorrhoids and fissures occur commonly and 
may be difficult to manage. In Salmon's series 25% had diarrhea at 
165 
the end of the first year after surgery and only 13% after 2 to 3 years. 
In the present series, 28/30 patients reported that diarrhea had been a 
problem; 14 said that even 2 years after surgery they still had episodes 
of diarrhea, often related to certain foods. However only one of these 
patients reported the need for an anti-motility agent. 
Metabolic. The severity of metabolic changes after surgery generally 
parallels the severity of the diarrhea. Most cases of electrolyte im¬ 
balance can be managed on an outpatient basis with careful follow-up. 
The incidence of electrolyte imbalance requiring hospitalization is any- 
20 
where from 0 to 23% in reported series. Only 2 instances of severe 
electrolyte imbalance are known to have occurred in this study (2.1%), 
but follow-up was incomplete. 
Hypokalemia is the most frequently encountered problem. Starkloff 
191 
noted this in 28% of his 300 patients. Three of Scott's patients 
with 12+6 bypasses required oral potassium supplementation for months. 
Hypocalcemia is also common. Calcium precipitates in the gut with un¬ 
absorbed anions, particularly fatty acids. Vitamin D deficiency secondary 
to malabsorption and hypomagnesemia may underlie or exacerbate hypo- 
88 
calcemia. Routine supplementation with calcium and potassium does not 
necessarily prevent severe complications. One 36 year old woman died of 
hypocalcemia 8 months post-bypass, despite calcium supplementation when 
44 her symptoms first appeared. 
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The immediate complications of electrolyte imbalance are serious 
enough, but no one really knows what the long-term effects may be. De¬ 
creased calcium absorption with a negative calcium balance can be expected 
to produce osteomalacia, although this has not yet been reported. Depleted 
stores of potassium and magnesium may result in renal complications over 
146 
a long period of time. Data simply is not yet available to assess 
these and other possible consequences. 
Other metabolic complications include vitamin deficiency, hypo- 
proteinemia, and anemia. Potentially, any vitamin deficiency may develop 
87 
after jejunoileostomy. Becuase of steatorrhea, fat soluble vitamins 
are especially likely to be malabsorbed. Scott showed that levels of 
vitamins A and E fall after bypass. In addition he found a prolonged 
prothrombin time in several patients during the early post-operative 
months, suggesting a deficiency of vitamin Vitamin D malabsorption 
88 
may also occur, leading to hypocalcemia. 
Hypoproteinemia and anemia may develop from malabsorption. Amino 
acid patterns are typical of malnutrition for the first 3 to 4 months 
_ 126 t i 
after surgery. In general this reverses, but on occasion severe wasting 
and edema develop. When hypoproteinemia is extreme re-anastomosis is 
indicated. Evidence of a milder, chronic protein malnutrition is sug¬ 
gested by changes in hair growth. Patients frequently complain of hair 
loss after bypass surgery. Buchwald et al reported this complication 
in 5 of 140 patients. Examination of hair follicles revealed a defi- 
28 
ciency of keratin. In the present series, 15 of 30 subjects who answered 
the questionnaire reported significant hair loss. Several reported that 
their hair was still thin and fine in texture two years after surgery. 
Hyperuricemia has been observed after bypass surgery, but clinical 
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191 gput is uncommon (2% of Starkloff's 350 patients). Both Scott and 
Weismann reported that uric acid levels rose during the first post- 
175 217 
operative month, only gradually returning to pre-operative levels. * 
Weismann also noted a starvation ketosis in the early post-op period 
217 
before a full diet was tolerated. Competition of ketoacids with uric 
19,101 
acid for renal tubular reabsorption may underlie the hyperuricemia. 
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C. LATE COMPLICATIONS 
Liver failure. An increase in fatty infiltration of the liver with 
occasional rapid progression to complete liver failure is the complica¬ 
tion of most concern post-jejunoileostomy. It has been responsible for 
the greatest number of deaths. The exact frequency of this complication 
is difficult to determine accurately, for reasons which will become 
apparent. 
Fatty liver is commonly present in the obese. Various series of 
intraoperative biopsies on jejunoileostomy patients report fatty infil¬ 
tration in 60-100%, almost always without other pathological changes 
and frequently in the face of normal liver function tests.202 
Follow-up biopsies after surgery show that fatty infiltration increases 
in most patients. Fatty infiltration becomes particularly prominent 
165 
during the first 6 months after surgery, when weight loss is rapid. 
When symptoms occur, they tend to be gastrointestinal, e.g., nausea, 
vomiting, abdominal pain. The liver may be large and tender.Most 
patients recover spontaneously, and biopsies over a year after surgery 
202 
ordinarily show a decrease in fatty infiltration. However progressive 
changes develop in 3-5% of patients. These patients present clinically 
with weakness and lethargy. Liver function tests usually reveal non¬ 
specific changes; often, in fact, they remain normal until late in the 
course. Although the BSP retention is sensitive and may lead to early 
suspicion of an abnormality, it cannot be relied upon. Technetium liver 
scans show a diffuse decrease in uptake compared to pre-operative scans, 
81 
which may be helpful in diagnosis. Serial biopsies remain the best 
19 
way of following the condition. Early biopsies show an increase in 
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centrilobular fat. Fatty vacuoles may completely replace hepatocytes. 
Portal fibrosis and focal periportal necrosis develop. Bile duct pro¬ 
liferation and micronodular cirrhosis appear later. The terminal picture 
20 
may be indistinguishable from alcoholic cirrhosis. 
The incidence of severe and fatal liver disease is reviewed in Table 
17. Two cases of hepatitis occurred in the Montana series, one of which 
was followed by sudden death (attributed to a pulmonary embolus). The 
incidence of liver disease in this series is probably underestimated 
because of the number of patients lost to follow-up. 
TABLE 17 
Liver Disease Post-Jejunoileostomy 
Series Non-fatal liver disease(%) Deaths, liver failure 
Scott (175) 2/ 30 (6.6%) 0/ 30 
Salmon (165) 1/120 (1%) 0/120 
Buchwald (28) 2/94 (2%)* 0/ 94 
Fikri (52) 0/ 52 1/ 52 (2%) 
Weismann (217) 2/123 (1.6%)+ 1/123 (0.8%) 
Jewell (87) 0/ 52 0/ 52 
Payne (148) 0/165 4/165 (2.4%) 
Benfield (20) 0/ 30 1/ 30 (3.3%) 
Starkloff (191) 3/475 (0.6%) 4/475 (0.8%) 
* one reanastomosed; one treated with feeding jejunostomy 
into bypassed loop. 
+ attributed to drug or anesthesia 
Although liver failure ordinarily develops in the first year after 
bypass, it has become clear that it is not related to either the rate or 
20 degree of weight loss, despite early reports to the contrary.- Perhaps 
the most convincing evidence in this regard comes from serial biopsies 
in patients who lost weight by dieting or fasting. Pre- and post-fast 
liver biopsies were compared in 10 patients who lost an average of 90 
pounds over 71 days. Post-fast liver biopsies showed a marked decrease 
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in fatty infiltration. In a group of 7 patients who lost an average of 
131 pounds over 5 months by dieting, even more complete regression of 
the fatty infiltration was noted. Long-term follow-up (average 17 months) 
in 14 subjects from both groups revealed essentially normal biopsies in 
9, with minor (borderline) abnormalities in 5.^ Rozental's study of 5 
fasting patients confirms the above data. Even during starvation, 3 of 
163 
the 5 had demonstrably less fatty infiltration. 
Theories to explain the progressive liver failure focus on either a 
nutritional deficiency or a toxin. It has been shown that in the first 3-4 
months after bypass patients have amino acid levels typical of malnutri¬ 
tion (low fasting levels of most amino acids except for glycine and 
serine, which may be elevated). With weight stabilization these abnor- 
12 6 
malities reverse themselves. Although the protein deficiency of 
kwashiorkor is associated with a prominent fatty infiltration of the 
liver, one cannot conclude that protein deficiency is responsible for 
fatty liver in bypass patients. In fact, there is evidence that liver 
function post-bypass may improve despite continued protein depletion, and 
may deteriorate even with adequate protein nutrition via hyperalimenta- 
20 
tion. Other nutritional deficiencies are postulated, including vitamin 
102 
E, essential fatty acids, and choline , but none of these has been 
linked directly to the liver failure seen post-jejunoileostomy. 
Toxic substances may be responsible for liver damage after bypass. 
Lithocholic acid, which causes cirrhosis in a number of mammals, is a 
secondary bile acid resulting from bacterial action on chenodeoxycholic 
31 
acid. Ordinarily the primary bile acids are reabsorbed in the terminal 
ileum and recycled by the enterohepatic circulation. Primary bile acids 
that escape intestinal absorption are available for bacterial deconjugation 
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in the colon, and their end-products like lithocholic acid can be absorbed. 
Moxley found a level of lithocholate 14 times normal in the serum of a 
f) 
patient with post-bypass liver disease. However lithocholate levels 
from bypass patients without liver disease are not available for com¬ 
parison. The lithocholate hypothesis is not supported by the fact that 
patients undergoing ileal bypass for hyperlipidemia, in contrast to those 
2 8 
with jejuno ileostomy, do not develop liver failure. Alcohol has been 
suspected in liver disease post-bypass, but thorough investigation has 
shown cases of liver failure in the absence of alcohol intake. At present 
122 
there is no evidence that alcohol, either endogenous or exogenous, 
plays a major role in liver failure post-jejunoileostomy. Patients are, 
however, advised to avoid alcohol post-op in order not to burden the 
liver with a known toxin. Recent work by O’Leary et al has focused at¬ 
tention on another possible liver toxin: bacterial endotoxin. These 
investigators performed 24+12 end-to-side bypasses in 8 dogs. Four re¬ 
ceived 100 mg. of Vibramycin daily in addition to a balanced diet, while 
the 4 controls received only a balanced diet. All 4 of the control dogs 
died of progressive fatty metamorphosis of the liver within 4 months of 
bypass. Bacteroides species and/or 13. fragilis was cultured from the 
small bowel. The 4 experimental dogs had no liver abnormalities and 
grew no anaerobic organisms. O'Leary postulates that a bacterial endo¬ 
toxin released from colonization of the defunctionalized loop of bowel 
may cause liver failure. This data does not exclude the lithocholate 
hypothesis, as the antibiotic may rid the bowel of organisms that decon¬ 
jugate and convert primary to secondary bile acids. 
Therapy for post-bypass liver disease is non-specific: correction 
of nutritional deficits, cholestyramine, amino acid supplementation, 
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antibiotics, hyperalimentation. Results have been mixed. Reanastomosis 
is indicated in the face of progressive liver disease, but even this may 
come too late to save some patients. * * ° it is the risk of liver 
failure which has turned many physicians away from the jejunoileostomy. 
Urolithiasis. Kidney stones are a relatively common complication 
of jejunoileostomy. Reported incidence ranges from 5 to 15%.^* In 
the present series three patients are known to have developed kidney 
stones (3.2%). Two consisted of calcium (one of these was negative for 
oxalate) and the third was not retrieved. This figure is probably low 
because of incomplete follow-up. Stones post-bypass commonly consist of 
calcium oxalate; in most cases patients with stones have hyperoxaluria, 
with normal serum calcium, phosphate, and uric acid and a normal 24 hour 
urine calcium. Increased oxalate absorption is responsible for the 
hyperoxaluria. Since oxalate is absorbed by passive diffusion, solubility 
is an important factor. Binder's in vitro studies show that calcium 
chloride reduces oxalate solubility; when oleate is added, oxalate solu- 
11 
bility increases. In patients with steatorrhea, calcium binds pre¬ 
ferentially to the abundant fatty acids (like the oleate in vitro) and 
more oxalate is available for absorption. Dehydration secondary to 
diarrhea is another major factor leading to urolithiasis. Therapeutically 
a low oxalate diet (avoiding tea, fruit juices, cocoa, beets, spinach) 
and liberal fluid intake are indicated. Calcium administration may be 
helpful. Cholestyramine decreases oxalate solubility in vitro", but has 
11 133 
not yet been successful in clinical trials. * 
Increased oxalate excretion in the absence of stone formation may 
cause renal damage. Vainder and Kelly report a patient who developed 
renal tubular acidosis (distal) seven years after bypass. Twenty-four 
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hour urinary oxalate was elevated and oxalate crystals could be demon- 
strated on renal biopsy. A second patient, also with elevated 24 
hour oxalate excretion, developed renal insufficiency 2 years after by¬ 
pass. Biopsy showed interstitial nephritis and calcium oxalate deposi- 
40 
tion. The latter can be a nonspecific finding in uremia , but the 
evidence is highly suggestive that oxalate may produce serious renal com¬ 
plications years after jejunoileostomy. 
Other GI complications. A number of gastrointestinal complications 
in addition to diarrhea and liver failure have been reported. Intussus¬ 
ception is currently a rare complication because the operative procedure 
includes anchoring the blind loop to the mesentery or the bowel itself. 
Internal herniation through mesenteric defects and volvulus have both 
74 
been reported. Obstruction may arise secondary to adhesions, as occurred 
in one patient in the present series. Ventral or incisional hernias are 
common. In the current series 5 were repaired; 2 recurred and required 
surgery a second time. 
Passaro described a syndrome of "bypass enteritis" occurring 2 to 
20 weeks post-operatively. It is characterized by an abrupt increase in 
diarrhea, with abdominal pain, distension, and fever. Diagnosis may be 
difficult, and patients have gone to laparotomy for presumed peritonitis 
or obstruction. Operative findings are inflammation, dilatation, and 
edema of the bowel. Pneumatosis cystoides of the defunctionalized segment 
145 
is common. The pathophysiology of this syndrome has not been entirely 
explained, but it is thought to be inflammatory in nature. If the diag¬ 
nosis is considered, laparotomy may be avoided, since patients respond to 
antibiotics. Short-term antibiotics also relieve symptoms of bloating 
and gas associated with bacterial overgrowth of the defunctionalized limb 
- 
88 
(blind loop syndrome) 
Reports of the "development" of gallstones post-bypass are difficult 
to interpret, since an oral cholecystogram is not a part of the routine 
pre-op work-up. Sorrell et al report 3 cases of acute pancreatitis due 
to stone impaction: in all three cases, the gallbladder was normal to 
187 
palpation at bypass. Potentially, the cholesterol:lecithin+bile salt 
ratio may be upset by the large losses of bile salts that occur post- 
129 223 bypass. * However, Buchwald states that in 140 cases he has not 
28 
seen any instance of gallstones developing after surgery. 
Megacolon has occurred after jejunoileostomy, particularly in patients 
undergoing end-to-end anastomosis. Fikri reported 3 cases in his series 
52 
of 52. One patient in the present study was treated for this complica¬ 
tion at another hospital. The area of dilatation of the colon is related 
to the point at which the defunctionalized loop of bowel drains: every¬ 
thing distal to that point will be affected. In an end-to-side procedure, 
this means the entire colon; in an end-to-end bypass it generally means 
the transverse, descending, and sigmoid colon. The blind loop contents 
have been blamed for this condition. Large numbers of obligate anaerobes 
can be cultured from the vicinity of the defunctionalized limb. (Colonic 
dilatation or pseudo-obstruction is also seen in other diseases associated 
with bacterial overgrowth, such as scleroderma and jejunal diverticulosis.) 
Treatment is primarily surgical because resistance to antimicrobial 
agents develops quickly.^ 
Mason and Printen report a patient who developed celiac sprue after 
bypass. Her symptoms did not improve with reanastomosis, but she did 
respond to a gluten-free diet. These authors suggest that jejunoileo- 
stomy might produce mucosal atrophy in the bypassed segment of bowel; if 
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this occurs, these patients could be predisposed to intestinal lymphoma 
or cancer. They suggest that atrophic small bowel mucosa be a strong 
114 
indication for reanastomosis. 
Arthritis. A tenosynovitis and symmetrical polyarthritis has been 
described after intestinal bypass surgery. It occurs in about 10% of 
patients. In response to the questionnaire, 6 of 30 patients reported 
"joint pains" and 2 more had seen their doctor for "gout". One patient 
described stiffness of her hands and arms which appeared in the first 
few months after surgery and resolved gradually with physical therapy. 
Shagrin reported on 7 patients with jejunocolic bypass who developed 
arthritis. The wrist was affected in all 7 cases, the fingers in 5, and 
the knees and ankles in 3 each. Lab parameters, including RF, ANA, LE 
prep, creatinine, uric acid, calcium, phosphate, alkaline phosphatase, 
and cholesterol were entirely normal. He was able to control symptoms 
in 5 with rest and aspirin, but one patient required reanastomosis and 
another was still on steroids at the time of his publication. The patient 
who was eventually reanastomosed had a remission of her symptoms while 
179 
treated with a course of tetracycline for a concurrent infection. 
Buchwald noted 2 cases of polyarthritis in 140 end-to-end jejunoileo- 
stomies. When these patients discontinued the use of diphenoxylate for 
diarrhea, the symptoms abated. He suggested that a drug reaction was 
28 
responsible. However an equally reasonable explanation might be that 
the drug-induced decrease in motility had encouraged bacterial overgrowth. 
More recently, circulating cryoglobulin complexes containing IgG, IgM, 
IgA, C3, C4, and C5 were isolated from the serum of 3 patients with 
arthritis post-bypass. IgG against E^. coli and _B. fragilis was identified 
in the cryoglobulins. Two of the 3 patients had serum containing early 
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factors in the alternate activation pathway of complement. Both these 
factors and the cryoglobulin complexes disappeared when the arthritis 
resolved. Wands and his colleagues theorize that bacterial overgrowth 
occurs in the defunctionalized loop of bowel and that bacterial antigens 
reach the systemic circulation. Here cryoglobulin antigen-antibody 
complexes are formed that fix complement, activating it by either the 
classic or alternate pathway. These cryoglobulins are thought to play 
212 
a key role in the pathophysiology of the arthritis. 
Miscellaneous. Brief mention should be made of a few other potential 
problems. It has been found that drug absorption is unpredictable post¬ 
bypass. The birth control pill must be considered an unreliable means 
of contraception in this population. Particular care must also be taken 
13 
in the use of the coumadin/warfarin family of drugs. 
The small intestine is an immune organ, and one must ask what effects 
the bypass procedure will have on the body's defenses. Intestinal anti¬ 
bodies ("copro-antibodies") are known to protect animals from cholera, 
while circulating antibodies will not.~^ Studies of Peyer's patches have 
suggested that they are an important interface between antigens in the 
144 
intestinal lumen and the body's lymphocytes. Several cases of primary 
7 152 
and reactivation TB have been reported after bypass. * The increased 
incidence of TB post-gastrectomy, although unexplained, has been recog¬ 
nized for many years; it is not known whether a parallel situation exists 
after jejunoileostomy or whether the state of protein depletion or some 
other factor plays the key role. 
The long-term effects of such a drastic reorganization of anatomy 
are only now becoming apparent and will gradually be recognized and ex¬ 
plained as careful follow-up is undertaken. 
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D. REANASTOMOSIS 
Reversal of the bypass is done for a variety of reasons but is ordi¬ 
narily performed because of severe complications: intractable diarrhea 
and weight loss, uncontrollable electrolyte imbalance, liver failure. 
It has been necessary to take down the bypass in 0 to 3% of reported 
cases, as shown in the following table: 
TABLE 17 
REANASTOMOSIS OF JEJUNOILEOSTQMY 
REASON 
SERIES NUMBER(%) MALNUTRITION LIVER MEGACOLON OTHER 
Scott (175) 
Salmon (165) 
Buchwald (2 8) 
Fikri (52) 
Weismann (217) 
Jewell (87) 
Payne (148) 
Benfield (20) 
Starkloff (191) 
1/ 62 (1.6%) 
0/120 
1/ 94 (1%)* 
0/ 52+ 
2/123 (1.6%) 
1/ 52 (2%) 
4/140 (2.8%) 
1/ 30 (3.3%) 
4/475 (1%) 
X 
X 
X 
X 
x* 
x^ 
* 1 other patient underwent partial refunctionalization for refractory 
hypocalcemia. 
+ 4/52 required partial refunctionalization to relieve intractable weight 
loss, diarrhea, and electrolyte imbalance, 
x acute ulcerative colitis, unresponsive to therapy. Follow-up sigmoido¬ 
scopy 1 year later showed persistent ulcerative colitis. 
+ either for electrolyte imbalance or "alarming change in results of their 
liver function tests." 
# "secondary to psychogenic vomiting" 
^ 3 cases: patient’s request; patient unable to follow post-op instructions 
"glomerular nephritis." 
In the present series, a similar rate of reanastomosis was seen (1%). 
Only one patient had her bypass taken down during what she describes as 
a 3-4 month hospitalization for "kidney trouble." Other indications for 
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reanastomosis recommended by most surgeons include the severe polyarthritis 
that may occur post-bypass. As was noted above. Mason and Printen propose 
114 
that an atrophic small bowel mucosa be an indication for reanastomosis. 
If patients find themselves debilitated by fatigue and lassitude despite 
a stable adequate weight and normal electrolytes, they may request reana¬ 
stomosis . 
Warren brings up a point of concern in regard to reanastomosis. He 
performed a feeding jejunostomy into the bypassed segment of bowel for 
nutrition in a woman who developed cirrhosis 2 years after jejunoileostomy. 
Surprisingly, he found the blind loop virtually non-functional. How 
commonly this occurs is not known, but it does raise the question of whether 
the bypass procedure is in fact reversible in the long run. 
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E. PATIENT SATISFACTION 
Solow et al investigated patient satisfaction with the bypass pro¬ 
cedure as a whole. Of 29 patients interviewed, 23 replied that they would 
repeat the procedure; 4 were "tentatively satisfied"; and 2 were dis¬ 
satisfied. The 2 dissatisfied patients were disappointed in the degree 
186 
of weight loss achieved. Benfield also found a high degree of patient 
satisfaction: 97-100% of his 30 patients were satisfied with the procedure 
He notes, however, that only 13 of 27 were entirely asymptomatic at the 
time, and states that the surgeon was satisfied with the overall results 
20 in only about 50% of the cases. 
In this study, 23 of 29 patients voluntarily answering questionnaires 
replied "definitely yes" when asked if they would "do it all over again." 
Three said "probably yes," 3 "probably no," and 1 definitely would not 
repeat the procedure. There was no apparent relationship between either 
weight loss or the number of complications circled on the questionnaire 
and the patient’s satisfaction with the procedure, but 3 of the 4 patients 
who were dissatisfied mentioned side effects as the reason. 
Although patients are often ecstatic about successful weight loss, 
20 
can the physician ignore the risks? In subjects with serious, life¬ 
shortening complications of their obesity such as hypertension and dia¬ 
betes, a strong case can be made for jejunoileostomy. Degenerative 
arthritis, venous stasis, job and social discrimination are also crippling 
and only the patient knows just how disabling. Patient satisfaction is 
not physician satisfaction. As one patient stated, "If I should die ten 
years before my time I'd rather have had two years of being slim." It 
has always been the physician's responsibility to recommend the course 
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which is in the patient's best interest, and the case of jejunoileostoray 
can be no exception. As such it presents the physician with a difficult 
clinical judgment. 

IV. SUMMARY AND CONCLUSIONS 
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The complications of obesity and morbid obesity have been 
reviewed. Of particular importance are hypertension, elevated serum 
cholesterol levels, diabetes mellitus, degenerative arthritis, 
venous stasis, and the Pickwickian syndrome. Medical management of 
morbid obesity does not consistently produce maintained weight loss. 
The most commonly performed surgical procedure for obesity is the 
jejunoileostomy, or intestinal bypass. 
A follow-up of 93 cases of 10+8 end-to-side jejunoileostomies 
performed in rural Montana has been presented. Average pre-operative 
weight was 263 + 6 pounds (range 162 to 466 pounds). Patients' ages 
varied from 16 to 61 years. There were 14 men and 79 women. Average 
weight loss at one year after surgery was 79 + 4 pounds; more than 
two years after surgery, weight loss averaged 95+6 pounds. Weight 
loss at one year was correlated with pre-operative weight (r = 0.70). 
A correlation was found between pre-operative systolic blood pressure 
and relative weight; however the correlation was much less marked 
when age was taken into account. Blood pressure fell significantly 
in both hypertensive and normotensive patients after surgery. Both 
systolic and diastolic pressures fell to a greater degree in patients 
who were hypertensive prior to surgery. A marked early decline in 
blood pressure in hypertensives appeared to account for the entire 
difference, and it is suggested that obese hypertensives may be more 
sensitive to changes in fluid and/or salt balance than normo-tensives. 
Although a direct relationship between weight loss and change in 
blood pressure could not be demonstrated, the two variables were 
correlated in hypertensive women on long-term follow-up. Eighteen 
of 28 pre-operative hypertensives (64%) became normotensive after 
surgery. 
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In terms of complications, there were 4 deaths (4.3%), all 
occurring within one month of surgery. One was related to a techni¬ 
cal error and the other 3 were attributed clinically to myocardial 
infarction or pulmonary emboli. Morbidity in this series was com¬ 
parable to that reported elsewhere, namely wound infections: 6.4%; 
liver disease: 2.1%; hypokalemia/hypocalcemia (requiring hospitaliza¬ 
tion): 2.1%; urinary tract stones: 3.2%. Information on compli¬ 
cations such as liver failure, arthritis, gallstones, and anemia was 
not available for this report. Because of the number of patients 
lost to follow-up, the incidence of other complications has probably 
been underestimated. Four patients (4.3%) underwent revision of the 
bypass for inadequate weight loss. A single reanastomosis was per¬ 
formed because of renal impairment. There appeared to be little 
change in the work status of these patients, and the same number 
were on Welfare after surgery as before. In general patients seemed 
to be satisfied with the procedure: 23 of 29 who returned questionnaires 
stated that they would definitely "do it all over agains." 
In conclusion: 
(1) Morbid obesity has serious, life-shortening compli¬ 
cations. Many of these, including hypertension, diabetes, hyper¬ 
cholesterolemia, and the Pickwickian syndrome, can be partially or 
completely reversed with weight loss. 
(2) Medical management has often failed to produce permanent 
weight loss in the morbidly obese patient. 
(3) Jejunoileostomy is a reasonable alternative to medical 
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management in certain cases of morbid obesity. 
C4) Because of serious known complications of this proce¬ 
dure and a number of postulated but as yet unreported complications, 
strict criteria must be used in selecting patients for jejunoileostomy. 
C5) These criteria include 
(a) morbid obesity 
(b) failure of vigorous medical management 
(c) absence of correctable endocrinopathy 
(d) serious complications of obesity which can be 
expected to improve or reverse with weight loss 
(including consideration of the psychosocial 
burden of morbid obesity). 
(6) Careful follow-up after surgery is of critical impor¬ 
tance, and patients should not be accepted for the procedure if they 
cannot be seen at regular intervals afterwards. 
(7) Finally, it is not essential that a surgeon, internist, 
and psychiatrist work with each patient, nor is it necessary that 
the procedure be performed in a university setting. Although this 
may be an ideal situation, good results can be achieved in a 
community hospital. 

APPENDIX A 
QUESTIONNAIRE 
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GENERAL INFORMATION 
Date of operation: Sex: male/female 
Date of birth: Height: 
Weight before operation: % over ideal weight: 
Ideal weight: 
Present weight: 
Before surgery, when was the last time your weight was "normal"? 
What is the most you have ever weighed? 
What is the least you have weighed in the past ten years? 
WORK HISTORY 
Are you presently employed? full/part time? 
Describe your job: 
How long have you held this job? 
Have you ever been on Welfare? When? 
Please list below all the jobs you have had starting from five years 
before your surgery and including your present job. 
Type of work Employer Full/part Salary From To 
time mo/yr mo/yr 
MARITAL HISTORY 
Are you single/married/divorced/widowed/separated? (Circle) 
How many times have you been married? 
Please list years of all marriages below (example: 1953 to present). 

99 
How many children do you have? 
What are their ages? 
COMMUNITY ACTIVITIES 
Do you belong to a church? How long have you been a member? 
List any clubs or community organizations of which you are a member (Lions 
Club, Rotary Club, PTA, Sewing Circle, Ceramics Group, etc.). Behind each 
organization put the number of years you have been a member. 
Have you ever been an officer or committee chairman of any church or 
community organization? If so, please indicate your position and the 
dates you held it. 
HEALTH. 
Were any of the following a problem for you after your operation? (Underline) 
After each problem underlined, write how long it bothered you. 
Diarrhea Joint pains Anemia Weak spells 
Bloating (gas) Kidney stones Dizziness Vomiting 
Muscle cramps Gallstones (gallbladder disease) Abdominal cramps 
List the names of any medications you take every day: 
Have you been under a doctor*s care for any medical problems since your 
operation? If so, what? 
If you had it to do all over again, would you have this operation for 
your weight problem? (circle one) 
Definitely yes Probably yes Probably no Definitely no 
COMMENTS 
Thank you very much. Your cooperation is appreciated. 

APPENDIX B 
DETAILS OF LONGITUDINAL CHANGES IN BLOOD PRESSURE IN 21 PATIENTS 
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FIGURE 6A. Changes in blood pressure in 5 normotensive patients 
after surgery. 
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FIGURE 6B. Changes in blood pressure in 16 hypertensive patients 
after surgery. 

APPENDIX C 
PATIENT COMMENTS 
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"My only regret is that they didn't come out with (this) type of surgery 
when I was around 20 years old." 
"What a wonderful feeling to walk somewhere again with my family and 
enjoy it!" 
"I have lots of energy and feel fine mentally and physically." 
"I tire very easily and wish I didn't have to work." 
"I wouldn't want the weight back — but there are also a lot of drawbacks 
too but I am learning to live with them." 
"I am living a life that I feel would never have been my chance if not 
for the bypass." 
"This operation has made my life." 
"This operation has done a great deal for me and I certainly have not 
been sorry I had it done." 
"Because of the surgery, my entire outlook on life and myself has changed." 
"If I should die ten years before my time I'd rather have had two years 
of being slim." 
"I am very happy with my decision..." 
"I'd sure like a medication for bloating and gas." 
"I now go out on dates, I can buy clothes at a regular store, people do 
not constantly stare and make fun of me and my size." 
"Your life is changed entirely." 
"Feel approximately twenty years younger." 
"I feel great and had no problems." 
"...to this day I have never regretted it." 
"...I am now feeling better and more contented than I have for the last 
six years." 
"My only regret is that I didn't have it sooner." 
"I have been terribly sick this past year — was hospitalized a good part 
of last year." 
"But the effects that I have had since...are not worth it... I am not 
able to function properly." 
"I feel 100% better." 
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"It has given me tomorrows that would not have been there...if there is a 
lessening of years ahead because of this operation at least I am grateful 
for the ones I've had not looking like a Sherman tank..." 
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